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Abstract 18 
Developing a mechanistic understanding of the impact of food structure and composition on 19 
human health has increasingly involved simulating digestion in the upper gastrointestinal 20 
tract. These simulations have used a wide range of different conditions that have often very 21 
little physiological relevance and this impedes the meaningful comparison of results. The 22 
standardised protocol presented here is based on an international consensus developed by 23 
the COST INFOGEST network. The method is designed to be used with the standard 24 
laboratory equipment and limited experience to encourage a wide range of researchers to 25 
adopt it. It is a static digestion method that uses constant ratios of meal to digestive fluids 26 
and a constant pH for each step of digestion. This makes the method simple to use but not 27 
suitable for simulating digestion kinetics. Using this method, food samples are subjected to 28 
sequential oral, gastric and intestinal digestion while parameters such as electrolytes, 29 
enzymes, bile, dilution, pH and time of digestion are based on available physiological data. 30 
This amended and improved digestion method (INFOGEST 2.0) addresses a number of 31 
ambiguities in the original scheme such as the inclusion of the oral phase and the use of 32 
gastric lipase. The method can be used to assess the end points resulting from digestion of 33 
foods, to analyse the digestion products (e.g. peptides/amino acids, fatty acids, simple 34 
sugars, etc.) and evaluate the release of micronutrients from the food matrix. The whole 35 
protocol can be completed in ~7 days including ~5 days required for determination of 36 
enzyme activities. 37 
 38 
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Introduction 40 
The worldwide prevalence of diet-related diseases has been on the increase for the last few 41 
decades.1 Large scale human intervention trials have been used to correlate diet with the 42 
health of different demographic groups. However, to understand the physiological response 43 
to specific foods, it is necessary to follow the complex digestive processes within the human 44 
digestive tract in more detail. This can be achieved with invasive procedures such as 45 
aspiration from the stomach2 or small intestine3 or with less invasive imaging technologies 46 
(e.g. magnetic resonance imaging4) and wireless, telemetric systems2,5. Animal models are 47 
also widely used, though it generally involves animal death or surgical approaches placing 48 
cannulas into digestive organs to access the contents of the gastrointestinal tract. The 49 
relevance of animal models for understanding food digestion in humans is also regularly 50 
questioned. In summary, in vivo (human or animal) intervention trials can be difficult to 51 
undertake, unsuitable, expensive or not justifiable on ethical grounds. For these reasons, in 52 
vitro models have been used for many decades to simulate the digestion of food.  53 
Development of the Protocol:  54 
There are several types of in vitro digestion methods that are commonly used for food, which 55 
can be divided into static and dynamic methods. These models aim to simulate the 56 
physiological conditions of the upper gastrointestinal tract, namely the oral, gastric and small 57 
intestinal phases. Most dynamic models6-10 have been shown to be suitable for simulating the 58 
digestion of foods and pharmaceutical products in different population groups and for 59 
different purposes11. However, these models are relatively complex, expensive to set up and 60 
maintain, and therefore may not be available to the majority of food researchers.  61 
Owing to its simplicity, static models, which use a constant ratio of food to enzymes and 62 
electrolytes, and a constant pH for each digestive phase, have been widely used for many 63 
decades for food, animal feed and pharmaceutical purposes12-14. Static in vitro digestion 64 
models have been shown to be very useful in predicting outcomes of in vivo digestion15,16. 65 
There are standardised static models17 that vary in complexity18,19, which are used for 66 
simulating the gastrointestinal behaviour of pharmaceutical products (Pharmacopeia 67 
methods)17. Other static methods were developed for assessing the in vitro bioaccessibility of 68 
soil contaminants20, heavy metals in particular, or mycotoxins in food21. These methods, 69 
developed and standardised22 by the Bioaccessibility Research Group of Europe (BARGE) 70 
were based on available physiological data reported by landmark papers such as Dressman 71 
et al. 23 or the Geigy tables24. The static methods of the BARGE group and Pharmacopeia 72 
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procedures were important milestones in the evolution of standardised in vitro digestion 73 
methods. However, their experimental conditions, purpose and endpoint were found to be 74 
unsuitable for digesting food due to the complexity and variability of food structures as well 75 
as very different research questions in food science. This resulted in the use of a great 76 
number of digestion methods, reviewed by Hur et al.25, with slight but significant variations in 77 
parameters such as pH, duration, enzyme concentration and activity, composition of 78 
simulated digestive fluids, etc.  79 
Hence, the need for a harmonisation of digestion conditions was identified and the 80 
international INFOGEST26 network (www.cost-infogest.eu) of multidisciplinary experts (food 81 
science, nutrition, gastroenterology, engineering, enzymology, etc.) from more than 35 82 
countries was established. One of the primary outcomes of this network was an international 83 
consensus on a set of digestion parameters for a static in vitro simulation of adult digestion 84 
suitable for food. The method, generally referred to as the INFOGEST method, was 85 
published27 and experimental parameters were justified and discussed in great detail in 86 
relation to available in vivo physiological data. Some of the previous digestion methods 87 
outlined above were used as a starting point. Since its publication in 2014, this in vitro 88 
digestion method has received a Highly Cited Paper status for Agricultural Sciences with 89 
more than 550 citations in Web of Science and has been extensively used all over the world 90 
for numerous purposes, with a variety of foods and different endpoints. The current article 91 
builds on that publication and clarifies a number of aspects of the original protocol, leading to 92 
an improved INFOGEST 2.0 protocol described here.  93 
Overview of the Procedure 94 
The digestion procedure is summarised in Figure 1. It can be divided into three phases: 95 
preparation, digestion procedure and sample treatment with subsequent analysis. For 96 
preparation of the in vitro digestion, the activity of all digestive enzymes and the 97 
concentration of bile salts should be determined experimentally, using the recommended 98 
standardised assays for amylase, pepsin, lipase (both gastric and pancreatic), trypsin and 99 
chymotrypsin, outlined in Box 1, described in detail in the Supplementary Information. This 100 
first preparation step is of the utmost importance and failure to correctly assay enzyme 101 
activity will lead to incorrect rates of digestion of components (e.g. proteins)28, potentially 102 
changing the overall digestion of the food. 103 
The digestion involves the exposure of the food to three successive digestive phases: oral, 104 
gastric and intestinal. For static in vitro digestion methods, the experimental conditions are 105 
constant, during each phase. The oral phase involves dilution of the food 1:1 (w/w) with 106 
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simulated salivary fluid (SSF), with or without salivary amylase, and for solids or semi-solids 107 
simulated mastication of the food. If used, exposure of the food to salivary amylase is limited 108 
to two minutes at pH 7. The oral phase needs to be included in all simulated digestion 109 
procedures, regardless of the state of the food (liquid or solid) in order to provide consistency 110 
of dilution. Further clarification regarding the preparation of the food and the oral phase can 111 
be found in the Experimental Design. 112 
The oral bolus is then diluted 1:1 (v/v) with simulated gastric fluid (SGF) and gastric enzymes 113 
(pepsin and gastric lipase) and incubated under agitation at pH 3.0 for two hours. The gastric 114 
chyme is then diluted 1:1 (v/v) with simulated intestinal fluid (SIF), bile salts and pancreatic 115 
enzymes (pancreatin based on the activity of trypsin or as individual enzymes) and incubated 116 
at pH 7 for a further two hours. 117 
The experimental conditions for the digestion procedure such as pH, time of digestion and 118 
enzyme activity etc. were based on available physiological data of the fed state for a typical 119 
meal and were described and justified in detail in Minekus et al.27 For this improved 120 
INFOGEST 2.0 method, the use of gastric lipase is recommended, hence a detailed 121 
justification of the type and activity of the gastric lipase is provided in the Experimental 122 
Design section. 123 
The last step of the digestion procedure involves sampling, sample treatment, storage and 124 
subsequent analysis of samples. This step should be carefully considered prior to digestion 125 
as it may differ from case to case due to different endpoints, purposes of the digestion 126 
experiment and type of analysis. A description of sample treatment can be found in the 127 
Experimental Design and Table 1. 128 
  129 
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Advantages and limitations  130 
Static in vitro digestions are the simplest methods to simulate in vivo food digestion. While 131 
there are clear weaknesses in these simple models, they have obvious advantages over 132 
more complex methods. The main strengths of static in vitro models  is the good intra- and 133 
inter-laboratory reproducibility, robustness, simplicity, relatively low cost and easy 134 
assessment of each digestion phase. This latter point makes them very suitable for 135 
mechanistic studies, hypothesis building and screening. It was one of the aims of the 136 
INFOGEST network not just to standardise in vitro methods but to agree on experimental 137 
conditions that are based on available physiological data to be as close as possible to the in 138 
vivo equivalent, while keeping the method sufficiently simple to reproduce all over the world. 139 
The clear definition of standardised experimental conditions and procedures is one of the 140 
major advantages of the INFOGEST method. Egger et al. 28 showed very good lab to lab 141 
reproducibility of results from the in vitro digestion of skim milk from powder, in regards to 142 
peptide patterns. Some weaknesses were identified and have been addressed subsequently. 143 
The recommendation of standardised enzyme assays (including units) significantly added to 144 
the precision and reproducibility of the digestion procedure as previously, a number of 145 
common but slightly different enzyme assays were being used, resulting in the application of 146 
a wide range of enzyme activities during digestion experiments. The end point of this 147 
INFOGEST method was recently compared to digests obtained in human jejunum after 148 
casein and whey protein ingestion16 showing excellent correlation in protein degradation and 149 
peptide patterns, as explained below in Applications. 150 
However, static digestion methods have known limitations and cannot mimic the complex 151 
dynamics of the digestion process or the physiological interaction with the host. For example 152 
for the gastric phase, the pH is kept constant, there is a lack of the gradual addition of gastric 153 
fluid (acid, minerals, pepsin) and an absence of gradual gastric emptying. In addition, the 154 
enzyme activity in each digestive phase is kept constant, regardless of the type of food and 155 
whether the food contains high or low amount of substrate e.g. proteins, lipids and 156 
carbohydrates. The intestinal phase is treated as one phase rather than those of the 157 
sequential duodenal, jejunal and ileal phases, which exhibit different dilutions, mineral 158 
content, pH, enzyme activities, microbial content, etc. These shortcomings render the 159 
method unsuitable for detailed kinetic analysis of the different stages of the digestion 160 
process. However, in vivo comparison shows good correlation with the INFOGEST method 161 
at the end points of each digestion phase.16,29 For this reason, the static model should only 162 
be used to assess digestion endpoints and not kinetics. 163 
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In some cases, a slight alteration of the procedure may be considered to more accurately 164 
reflect physiological conditions. For example, during the gastric in vivo digestion of food 165 
containing probiotic bacteria, the bacteria are exposed to a range of pHs, as low 1 at the end 166 
of the gastric emptying. Hence, a static method with a constant pH of 3.0 for the gastric 167 
phase may fail to accurately predict probiotic survival and a lower pH or a dynamic gastric 168 
model should be chosen. Studying the bioaccessibility of phytochemicals such as 169 
polyphenols and carotenoids, the model allows the realistic release from a food into the 170 
aqueous phase. However, specific hydrolytic processes occurring at the brush-border are 171 
currently not simulated, and additional steps such as centrifugation of the digesta are needed 172 
to separate the bioaccessible phases. An extension including colonic fermentation, an 173 
important step in the bioactivation of several phytochemicals, would further enhance the 174 
physiological appropriateness. Finally, for the assessment of the bioaccessibility of small 175 
amounts of contaminants in food, such as heavy metals, environmental pollutants, or 176 
mycotoxins, alternative methods reflecting extensive digestion and “worst-case scenarios”20 177 
can be applied. 178 
Applications 179 
The method described has been used to assess the release of carotenoids and phenolic 180 
compounds from different matrices, such as, carotenoids in fruits30,31, carotenoids in 181 
tomatoes compared to tomatoes subjected to pulsed electric fields32, β-carotene protected by 182 
microencapsulation33 and resveratrol encapsulated in protein nanoparticules34. However, 183 
most studies have been dedicated to the evaluation of protein, lipid and starch digestion in 184 
foods or modified carriers. Protein digestion has been widely assessed in different dairy 185 
products35,36, or in isolated milk proteins, such as lactoferrin with different iron contents and 186 
after mild heat treatment37. The stability of proteins to gastrointestinal digestion has been 187 
proposed as an additional piece of information for the allergenicity assessment of novel 188 
proteins38. With this focus, the INFOGEST method was also applied to the study of the 189 
immunogenic potential of peptides from pasta39, hazelnut40, and peanut41, which are resistant 190 
to gastrointestinal digestion. Using a pH-stat to monitor enzymatic hydrolysis, it was shown 191 
that solid emulsions led to a lesser extent of lipolysis but a greater degree of proteolysis 192 
compared to liquid emulsions due to the higher sensitivity of denatured whey proteins to 193 
gastrointestinal enzymes42. The tendency of dairy rennet gels to form compact protein 194 
aggregates during gastric digestion has also been assessed43. Other applications of this 195 
protocol include the evaluation of novel biopolymers designed for a controlled nutrient 196 
release44,45, or the digestive stability of transgenic microRNAs in genetically modified plants46. 197 
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An inter-laboratory trial applying different in vitro digestion protocols clearly demonstrated a 198 
good reproducibility obtained by using the standardised INFOGEST protocol. It also 199 
highlighted the importance of correctly applying standardised pepsin activity assays, which is 200 
a key factor for proper gastric protein hydrolysis28. A special effort was made to validate and 201 
compare the results from this in vitro digestion protocol with in vivo data. For instance, β-202 
cryptoxanthin bioavailability from pasteurised orange juice was found to be higher than from 203 
fresh oranges in a randomised crossover human study, and from the in vitro digestion an 204 
increased bioaccessibility could also be inferred47. Several studies have focused on protein 205 
digestion and the comparison with in vivo digestion in human or animal models. The results 206 
from the in vitro gastrointestinal digestion of skim milk powder were compared with in vivo 207 
porcine samples collected from the stomach and several sites in the intestine29. Protein 208 
degradation and peptides generated at the end of the gastric phase correlated well with in 209 
vivo gastric peptides while the in vitro intestinal phase correlated well with the in vivo 210 
samples taken in the median jejunum. Human jejunal digests after the oral ingestion of 211 
casein and whey protein were compared with the intestinal digests obtained using the 212 
standardised INFOGEST method16. In vivo and in vitro intestinal digests showed common 213 
protein regions that are resistant to digestion and a high number of identical peptide 214 
sequences, concluding that the INFOGEST in vitro method is a good approximation to the 215 
end points of gastrointestinal digestion of milk proteins in vivo. 216 
Alternative methods 217 
A wide variety of static in vitro digestion models can be found in the literature 25 but they all 218 
exhibit different conditions (pH, duration of each step, ratio enzymes/substrate…) making the 219 
comparison between studies impossible. The static methods published by Versantvoort et 220 
al.21, Garrett et al.48 and Oomen et al 20 are amongst the most used, based on their citations. 221 
However, most of the of static in vitro digestion methods found in the literature simulate the 222 
fasted state, which is quite far from the physiological conditions when food is digested in the 223 
gastrointestinal tract. Advantages and limitations of static in vitro digestion models have been 224 
recently reviewed by a group of experts within the INFOGEST network15. While static 225 
methods can be useful for understanding trends or performing a screening of samples, it falls 226 
short in terms of some of the important dynamic processes occurring during gastrointestinal 227 
digestion, namely the pH gradients and the gradual addition of enzymes and gastric fluid as 228 
well as continuous gastric emptying. More physiologically relevant dynamic digestion 229 
methods6-10 take these and other factors into account. However these models are highly 230 
complex, require substantial hard- and software and are still expensive to set up and 231 
maintain, hence are often not available to food researchers. It has recently been shown that, 232 
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when human data are available to set up the system, these models can be physiologically-233 
relevant11. In an effort to improve in vitro digestion methods, a low-cost semi-dynamic 234 
method was recently developed49 and described in detail50, where parameters were based on 235 
the equivalent in vivo data from the digestion of dairy products. Here, the simulated gastric 236 
fluid (SGF) and pepsin are slowly added to the food in a suitable reaction vessel with 237 
manual, stepwise gastric emptying. A harmonisation of experimental conditions is currently 238 
on-going and a standardised semi-dynamic method will be published shortly by INFOGEST 239 
members , coordinated by A.R Mackie. 240 
Even though they are expensive and must be ethically justifiable, in vivo models have been 241 
widely used for studying the digestive process. The pig model can closely simulate the upper 242 
part of the human digestive tract (stomach and small intestine)51. Conventional pigs or mini-243 
pigs can be used for this purpose and can be equipped with cannulas in order to sample the 244 
effluents throughout digestion and a catheter to collect blood, whereas piglets can be used 245 
for all the questions related to neonatal nutrition29,52,53.  246 
Finally, human volunteers can be equipped with naso-gastric or naso-intestinal probes to 247 
access and sample the digestive effluents3. Ileostomy patients have been used to study 248 
digestion54-56 but can hardly be considered as a model of a healthy human since they are 249 
affected by digestive pathologies. 250 
 251 
Experimental Design 252 
Enzyme assays 253 
The determination of the standard units of activity of the enzyme used in the protocol is a 254 
crucial step and one of the main sources of variation in results with the digestion periods or 255 
between different laboratories.37 Enzyme activity determination is recommended for each 256 
new batch of enzyme or after prolonged storage. 257 
Enzyme and bile assays were previously described in protocol format in the Supplementary 258 
Materials of Minekus et al.27, namely: α-amylase (EC 3.2.1.1), pepsin (EC 3.4.23.1), trypsin 259 
(EC 3.4.21.4), chymotrypsin (EC 3.4.21.1), pancreatic lipase (EC 3.1.1.3) and bile salts 260 
(according to supplier´s protocol). In order to improve the reproducibility of the pepsin activity 261 
assay for this revised INFOGEST 2.0 protocol, it is now recommended to dissolve pepsin in 262 
10 mM Tris buffer (tris-hydroxymethyl-aminomethane), 150 mM NaCl, (pH 6.5), instead of in 263 
sodium chloride solution adjusted with sodium hydroxide. The buffering capacity of Tris 264 
buffer reduces the variability in the measurement of the pepsin activity, as shown 265 
previously37. The detailed protocols for the complete set of enzyme and bile assays, including 266 
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that of the gastric lipase assay (EC 3.1.1.3), can be found in the Supplementary Information 267 
and is summarise in Box 1.  268 
Spreadsheets for the enzyme assays and the volumes for the digestion procedure are 269 
provided in the Supplementary Information of this manuscript. The enzyme assay 270 
spreadsheets (Supplementary spreadsheets 1) can be used to calculate the enzyme 271 
activities of all digestive enzymes. The digestion spreadsheets (Supplementary spreadsheets 272 
2) provides help in calculating all volumes of simulated digestive fluids, enzyme and bile 273 
solutions based on the initial amount of digested food; one example is shown in Table 3. The 274 
corresponding online spreadsheets can also be used, and are available here: 275 
www.proteomics.ch/IVD and on the INFOGEST website https://www.cost-infogest.eu/ . In 276 
addition, videos of the digestion procedures (Supplementary Video 1 and 2) and all enzyme 277 
activity assays (Supplementary Video 3 to 7) are available in the Supplementary Information. 278 
In addition, the videos are also available online on the YouTube channel “In vitro food 279 
digestion - COST action INFOGEST” https://www.youtube.com/channel/UCdc-280 
NPx9kTDGyH_kZCgpQWg and on the INFOGEST website https://www.cost-infogest.eu/. 281 
Food preparation and oral phase 282 
It is important to plan the preparation of the food and the oral phase prior to in vitro 283 
gastrointestinal digestion to determine the food to digestive enzyme ratio throughout the in 284 
vitro digestion process. Firstly, consideration should be given as to whether the food to be 285 
digested in vitro is consumed as a meal, a meal portion or even a food ingredient. Some 286 
foods such as milk are often consumed on their own or as part of a meal. Other foods or food 287 
ingredients are nearly always consumed as part of a meal rather than on its own (e.g. 288 
coconut milk, spices, pure proteins, oils). Hence these foods should be prepared in a way 289 
that reflects real food or a meal, i.e. dilution, emulsification, integration into other foods, etc. 290 
High solid foods such as powders need to be reconstituted in liquids to make them a 291 
consumable food.  292 
An optional oral phase with a standardised 1:1 (w/w) ratio of food to simulated oral fluid for all 293 
foods (solid and liquid foods) was recommended by the INFOGEST method27 in 2014. While 294 
in vivo data varies greatly (Supplementary Figure 1), this dilution ratio enables the formation 295 
a swallowable bolus with almost all types of foods. For this revised INFOGEST 2.0 protocol a 296 
standardised, easy-to-follow approach for the oral phase is necessary. Hence, it is now 297 
recommended to dilute all food 1:1 (w/w) with simulated oral fluid to achieve a swallowable 298 
bolus that is no thicker than a paste-like consistency similar to that of tomato paste or 299 
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mustard at the end of the oral phase. If the consistency of the bolus is thicker than paste-like, 300 
add water to achieve it (see also Table 3 and Table 4 Troubleshooting). 301 
Use of lipase in the gastric phase  302 
Lipid digestion starts in the stomach with the action of preduodenal lipase (gastric lipase in 303 
humans, lingual lipase in rodents) on triacylglycerides (TAG) and some other esters57. 304 
Gastric lipolysis not only contributes to the overall digestion of TAG (10% with a solid-liquid 305 
test meal to 25% with an emulsified liquid test meal) but it also triggers the subsequent action 306 
of pancreatic lipase on lipid substrates that may be poorly digested by pancreatic lipase 307 
alone; examples include milk fat droplets and lecithin-stabilised TAG emulsions58. It is 308 
therefore recommended to add gastric lipase during the gastric phase of in vitro digestion. 309 
The mean gastric lipase concentration in human gastric juice is 100 µg/mL, which is 310 
equivalent to 120 U/mL using tributyrin as the reference substrate for gastric lipase59,60. In 311 
some static digestion models, a concentration of approx. 16 µg gastric lipase/mL (20 U/mL) 312 
has been used to reproduce gastric conditions at half time of gastric emptying61,62, which 313 
corresponds to a gastric juice to meal ratio of 1:5 v/v. In the INFOGEST method, the gastric 314 
phase of digestion includes a 1:1 dilution of the oral bolus by simulated gastric fluid, which 315 
would correspond to a dilution of gastric juice by half and thus a gastric lipase concentration 316 
of 60 U/mL. To date, access to commercially available gastric lipase, or an appropriate 317 
equivalent has been limited, hence gastric lipase has been omitted or lipases from alternative 318 
sources have been widely used. However, caution should be applied regarding the specific 319 
biochemical properties of these alternative lipases. Human gastric lipase (HGL), encoded by 320 
the LIPF gene, is stable and active between pH 2 and 7 with an optimum activity between pH 321 
4 to 5.4. HGL displays a SN3 stereospecificity for TAG hydrolysis leading to the preferential 322 
release of short/medium chain fatty acids from milk TAG61. It is resistant to pepsin hydrolysis 323 
and is not inhibited by bile salts. HGL can however be replaced by other preduodenal lipases 324 
from the acid lipase gene family of various mammalian species like dog63 and rabbit64. Rabbit 325 
gastric lipase is now commercially available (Lipolytech, www.lipolytech.com). Pre-duodenal 326 
lipases originating from the oro-pharyngeal tissues of young ruminants (pharyngeal lipase of 327 
calf, kid goat, lamb) may also be used and are commercially available for applications in the 328 
dairy industry (DSM for Capalase® K and Capalase® KL lipases; CHR Hansen for Lipase Kid-329 
Goat ST20, Lipase Calf 57 LFU, Spice IT™ AC and Spice IT™ AG; DuPont Danisco, Clerici-330 
Sacco). These preduodenal lipases are however less resistant to acid denaturation 331 
(threshold at around pH 3.5 65) than gastric lipase and pH conditions may have to be 332 
adapted. Their contents and activity should be estimated before use in in vitro digestion 333 
experiments, using the recommended standard gastric lipase assay27, see Supplementary 334 
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Information Section. So far, no commercially available lipase of microbial origin combines all 335 
the above properties of gastric lipase 61,66, and their use is not recommended at this time. For 336 
this revised INFOGEST 2.0 protocol, the authors recommend using rabbit gastric lipase, 337 
commercially available as rabbit gastric extracts (RGE) at 60 U/mL in the final gastric 338 
digestion mixture. However, since these extracts also contain pepsin67, the pepsin 339 
concentration/activity in the gastric phase has to be accordingly adjusted to the 340 
recommended value. 341 
Sampling, controls and test tube 342 
Before performing the protocol (time-lagged before the digestion experiment or one day prior 343 
to the digestion experiment), it is recommended to run one preliminary experiment, the pH-344 
test adjustment experiment, with the relevant amount of food, enzymes and bile for the 345 
entire digestion process. The aim of this pH-test adjustment experiment is to measure and 346 
record the amounts of HCl and NaOH used to reach the target pH in order to perform more 347 
efficient pH adjustments when running the digestion protocol. These volumes are indicative 348 
of the necessary volume of acids and bases needed for the gastric and intestinal phase. It 349 
has to be noted that for solid food, the pH changes are generally slower in response to 350 
addition of HCl or NaOH – it is important to remain patient and wait long enough for the pH to 351 
become stable - >5 min depending on food particle size and buffering capacity. 352 
If it is intended to take samples at different time points during digestion, it is recommended to 353 
prepare one tube per time point, e.g. prepare six digestion tubes for six time points. Because 354 
most foods are heterogeneous mixtures during digestion, sampling is more reproducible by 355 
starting digestion with individual tubes per time point. If the food sample has special 356 
requirements in terms of nutrient stability (e.g. light sensitivity, oxidation) the characteristics 357 
of the tubes should be adapted to these particular situations (opaque tubes, maintenance of 358 
the food samples on ice, etc). The end volume of the digest should be calculated to use the 359 
most suitable reaction vessel, e.g. 50 mL tubes, which allow properly mixing during all 360 
digestion phases. 361 
Optionally, a replicate test tube (stability test tube) can be prepared to evaluate food 362 
stability during exposure to simulated digestive fluids without enzymes or bile, for example 363 
after oral, gastric and intestinal phase. It can also be advisable to prepare an enzyme-blank 364 
tube, i.e., a digestion tube with all enzymes and bile but without food. This may be helpful to 365 
identify enzyme, bile salts or degradation products thereof during analysis of the digests. It is 366 
important to highlight that due to proteolytic enzyme autolysis, especially pepsin, enzyme-367 
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derived peptides can be detected in digesta which can be easily monitored with this blank-368 
enzyme tube. 369 
Intestinal phase, stop reaction and read out 370 
The intestinal phase of the protocol starts with the mixing of the gastric chyme with the same 371 
volume of the pre-warmed SIF. The pH is adjusted with the amount of NaOH previously 372 
calculated in the pH-test adjustment experiment. In this phase, two different options are 373 
given, (i) the use of pancreatin or (ii) the use of individual enzymes: porcine trypsin (100 374 
U/mL), bovine chymotrypsin (25 U/mL), porcine pancreatic α-amylase (200 U/mL), porcine 375 
pancreatic lipase (2,000 U/mL) and porcine pancreatic colipase in molar excess to lipase. 376 
The amount of pancreatin to be used in the intestinal phase of digestion is based on trypsin 377 
activity to achieve 100 U/mL in the final mixture. This calculation may result in low lipase 378 
activity for high fat containing foods or if fat digestion is the aim of the study. In this case, it is 379 
recommended to include additional lipase to get 2000 U/mL of lipase activity in the final 380 
mixture and colipase in a molar ratio 2:1 colipase to lipase, which corresponds approximately 381 
to a mass ratio 1:2 colipase to lipase. Since this will require the measurement of the lipase 382 
activity in the pancreatic extract and in the lipase preparation, the use of individual enzymes 383 
could be a preferred option. Similarly, because the activity of amylase in pancreatin can vary 384 
between batches and the activity can be too low to digest starch rich foods, the use of 385 
individual enzymes could also be a good option when following carbohydrate digestion. Bile 386 
salts are added to the intestinal mixture to reach 10 mM in the final mixture, after 387 
determination of the bile salt concentration in the commercial product (see Enzymatic 388 
Assays). There are several commercial options for bile salts but bovine bile is preferred 389 
because its composition is similar to that in humans64. Bile solubilisation requires exhaustive 390 
mixing which can be achieved, for instance, in a rotating wheel mixer at 37ºC for 30 min. 391 
In vitro digestion is carried out for a wide range of purposes and with different endpoints. In 392 
all cases, sampling, sample preservation and the post-treatment of samples after food 393 
digestion are critical and some adaptations could be needed depending on the particular 394 
requirements of each experiment (Table 1). For example, to stop pepsin activity, the pH of 395 
gastric samples must be raised to 7.0, either by the addition of 1 M sodium bicarbonate or 1 396 
N NaOH solution. The pH shift after the gastric phase is very effective in stopping pepsin 397 
activity and similar to in vivo conditions found in the duodenum56. If the pH increase is not 398 
desired, the use of pepstatin A, a highly selective inhibitor of aspartyl proteases like pepsin 399 
(Ki = 0.1 nM) has also been suggested
68. When gastric digestion is considered as an end 400 
point, sample snap freezing in liquid nitrogen followed by freeze-drying are recommended. 401 
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Raising the pH to 7.0 strongly reduces the activity of gastric lipase on long chain 402 
triglycerides58-60. Alternatively, the use of Orlistat® (tetrahydrolipstatin) is also recommended 403 
(gastric lipase half-inhibition time of < 1 min) to block gastric lipolysis61. Add Orlistat at a final 404 
concentration of 0.6 mg/mL (1 mM) to obtain an inhibitor to lipase molar ratio of 1,000, taking 405 
into account that the gastric lipase activity of 60 U/mL corresponds to 50 µg/mL or 1 µM 406 
lipase. 407 
After gastrointestinal digestion and in order to inhibit the different enzymatic activities of the 408 
digested samples, immediate snap freezing after sampling is necessary. However, when 409 
thawing the sample for subsequent analysis, residual enzymatic activities could significantly 410 
affect the stability of the samples. Therefore, addition of sufficient amounts of enzyme 411 
inhibitors against target digestive enzymes is strongly recommended. In the case of 412 
proteases, the addition of 5 mM of Pefabloc® SC (4-(2-Aminoethyl) benzenesulfonyl fluoride 413 
hydrochloride, AEBSF) with ability to irreversibly inhibit trypsin and chymotrypsin is 414 
recommended due to its lower toxicity in comparison with phenylmethylsulfonyl fluoride 415 
(PMSF)40. Alternatively, the use of Bowman-Birk inhibitor from soybean, a potent inhibitor 416 
against both trypsin and chymotrypsin having Ki values at nanomolar level, has been also 417 
recommended62. In order to inhibit lipolysis by pancreatic lipase, the use of 5 mM of 4-418 
bromophenylboronic acid has been reported63. Inhibition of pancreatic lipase by Orlistat is too 419 
slow (half-inhibition time > 5 min) to be used here61. For amylase inhibition heat-shock 420 
treatment, inactivation by ethanol or inhibition with 12% TCA have been used64, depending 421 
on the downstream sample analysis. Once the target inhibition occurs, the digests should be 422 
immediately snap frozen in liquid nitrogen and freeze-dried. 423 
When biological activity of digested samples has been evaluated, heat-shock treatment (in 424 
boiling water for 5 min) to irreversibly inactivate proteases may also be considered28. 425 
However, it should be noted that heat treatment is detrimental to the food structure, proteins 426 
in particular as heat treatment generally causes irreversible denaturation and aggregation. 427 
For cell culture assays, consider whether the use of Pefabloc or other enzyme inhibitors can 428 
affect the read out of the experiment, and whether the osmolarity needs to be corrected by 429 
dilution to physiological values (285-300 mOsm/kg H2O, pH 7-7.5) in order to avoid cell 430 
osmotic shock. Other combined procedures for removal or enrichment of certain food 431 
components such as defatting, centrifugation, dialysis, filtration and size exclusion 432 
chromatography are also commonly used. 433 
 434 
 435 
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 436 
 437 
Materials  438 
Reagents:  439 
- Ultrapure type I water, generated by a Milli-Q® system or similar (referred in text as 440 
water) 441 
- Human salivary α-amylase (Sigma-Aldrich, 1031) 442 
- Porcine pepsin (Sigma -Aldrich, P7012 or P6887) 443 
- Rabbit gastric extract (RGE) for gastric lipase (see section on gastric lipase above, 444 
currently supplied by e.g. Lipolytech RGE 25-100MG) Critical: RGE contains both 445 
gastric lipase and pepsin. 446 
- Bovine bile (Sigma-Aldrich, B3883, preferred option as composition in closest to that 447 
in humans), alternatively Porcine Bile (Sigma-Aldrich, B8631),  448 
- Porcine pancreatin (Sigma-Aldrich, P7545) or individual intestinal porcine enzymes 449 
(trypsin, chymotrypsin, amylase, lipase and co-lipase), see below optional reagents 450 
- CaCl2(H2O)2 (Merck 2382) 451 
- NaOH (Merck 9141) ! Caution: corrosive, causes severe skin burns and eye damage 452 
- HCl (J. T. Baker 6081) ! Caution: corrosive, causes burns, irritating to respiratory 453 
system 454 
- KCl (Merck 4936) 455 
- KH2PO4 (J. T. Baker 0240) 456 
- NaHCO3 (Merck 6329) 457 
- NaCl (Merck 6404) 458 
- MgCl2(H2O)6 (Merck 5833) 459 
- (NH4)2CO3 (Sigma-Aldrich, 207861) 460 
- Enzyme inhibitors options (see Experimental Design and Table 1) : 461 
o Pefabloc® SC (4-(2-Aminoethyl)benenesulfonyl fluoride, Sigma-Aldrich, 462 
76307) ! Caution: corrosive;  463 
o Pepstatin A (Sigma-Aldrich, P5318) 464 
o  Bowman-Birk inhibitor (Sigma Aldrich, T9777) 465 
o 4-bromophenylboronic acid (Sigma Aldrich, B75956) ! Caution: hazardous, 466 
corrosive, causes eye damage, harmful for respiratory system 467 
Chemicals for enzyme and bile tests: 468 
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- Pepsin test 469 
o Haemoglobin from bovine blood (Sigma-Aldrich, H6525-25G), 470 
o Trichloroacetic acid (Sigma-Aldrich, T6399-5G) ! Caution: Corrosive, causes 471 
severe burns to skin and eyes. Soluble in water with release of heat. 472 
- Gastric lipase test: 473 
o Taurodeoxycholate (Sigma-Aldrich, T0875-1G) 474 
o Tributyrin (Sigma-Aldrich, T8626; ≥99%) 475 
o Bovine serum albumin (Sigma-Aldrich, A7030; ≥98%) 476 
- Trypsin test:  477 
o TAME (p-Toluene-Sulfonyl-L-arginine methyl ester, Sigma-Aldrich, T4626-5G)  478 
- Amylase test: 479 
o Maltose Std. (Sigma-Aldrich, M5885-100G) 480 
o Soluble Potato Starch (Sigma-Aldrich, S5651-500G) 481 
o DNS (3,5-Dinitrosalicylic acid, Sigma-Aldrich, D0550-10G), ! Caution: 482 
Harmful if swallowed, Acute oral toxicity 483 
- Chymotrypsin test: 484 
o BTEE (N-Benzoyl-L-Tyrosine Ethyl Ester, Sigma-Aldrich, B6125-5G) 485 
- Pancreatic lipase test: 486 
o Sodium taurodeoxycholate (Sigma-Aldrich, T0875-1G) 487 
o Tributyrin (Sigma-Aldrich, W222305-1KG) 488 
- Bile acid determination 489 
o Bile acid kit (Sigma-Aldrich, MAK 309) or ECOLINE Acides Biliaires, Diasys, 490 
122129990313) or equivalent assay 491 
Reagents for optional protocol with individual enzymes: 492 
- Porcine trypsin (Sigma-Aldrich, T0303) 493 
- Bovine chymotrypsin (Sigma-Aldrich, C7762) 494 
- Porcine pancreatic α-amylase (Sigma-Aldrich, A3176) 495 
- Porcine pancreatic lipase (Sigma-Aldrich, L3126) 496 
- Porcine pancreatic co-lipase (Sigma-Aldrich, C3028) 497 
Food (for further examples see Anticipated Results Section) 498 
- Skim milk powder (SMP, Fonterra, NZ, low-heat organic, protein 42.34%, fat 0.89%, 499 
 lactose 49.8% (w/w)28 500 
 501 
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 502 
Equipment:  503 
- Standard laboratory centrifuge suitable for 50 mL tubes, 5,000 × g (e.g. Heraeus 504 
Megafuge 40R, 75004519, Thermo Fisher, Switzerland) 505 
- Standard laboratory vortex (e.g. Genius 3, IKA, 17.1377.01, HuberLab, Switzerland) 506 
- Standard laboratory pH Meter (e.g. 827 pH lab, 2.827.0214, Metrohm, Switzerland), 507 
electrode, designed for food systems (e.g. Sentek, P17/S7, pH electrode for food and 508 
dairy, 11981656, Fisher Scientific) 509 
- Overhead shaker/rotator; small volume up to 50mL (Rotator SB Stuart, 17.0014.02, 510 
Huberlab, Switzerland) 511 
- Incubator large enough to hold the above rotator (e.g. Termaks, B9000, Labtec, 512 
Switzerland), adjustable at 37°C 513 
- Electric or manual mincer (Eddingtons Mincer Pro, 86001, Amazon, or similar) 514 
- Eppendorf tubes (2 mL, 211-2120, VWR, Deutschland) 515 
- Centrifuge Plastic tubes (15 mL, 391-3450, 50 mL, 525-0399, VWR, Deutschland) 516 
- Micropipettes (e.g. Gilson P10 - P1000, VWR) and tips 517 
- Volumetric flasks for solutions 518 
- Glass beakers 519 
Reagent setup:  520 
Minimum volumes of stock solutions needed for the preparation of 400 mL of simulated 521 
digestion fluids 1.25× concentration:  522 
- 0.5 mL of CaCl2(H2O)2 (0.3M) 523 
- 30 mL of KCl (0.5M) 524 
- 6 mL of KH2PO4 (0.5M)  525 
- 65 mL of NaHCO3 (1M) 526 
- 25 mL of NaCl (2M) 527 
- 2 mL of MgCl2(H2O)6 (0.15M)  528 
- 2 mL of (NH4)2CO3 (0.5M)  529 
1 M NaOH and 1 M HCl: for pH adjustment of stock solutions of simulated digestion 530 
fluids 531 
Stock solutions can be prepared and stored in aliquots at -20°C for one year. 532 
Preparation of simulated digestion fluids at a 1.25× concentration  533 
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 534 
Simulated digestion fluids for oral (SSF), gastric (SGF), and intestinal (SIF) digestion phase 535 
are mixed at a 1.25× concentration using the electrolyte stock solutions and water according 536 
to Table 2 and can be stored at -20°C for one year. Critical: CaCl2 should be added 537 
immediately prior to the digestion experiment to avoid precipitation upon storage. Critical: All 538 
the volumes (Table 2) are calculated for 400 mL of a 1.25× concentrated storage solution 539 
and just before use they are mixed with the necessary quantities of enzyme and finally 540 
diluted to a 1× concentrated working solution (i.e. 4 parts of electrolyte solution + 1 part 541 
consisting of enzymes and water result in a 1× concentration of the digestion fluids). 542 
Simulated digestion fluids (1.25× concentrates) can be stored at -20°C for one year in small 543 
aliquots of appropriate size; e.g. for the experiment shown in Box 1, using 5 g of food, at 544 
least 48 mL of SSF, 88 mL of SGF, and 96 mL of SIF are needed. Critical: Dilute enzymes 545 
in cold solutions and keep them on ice until used. This will keep enzyme activity to a 546 
minimum. Critical: Pre-warm electrolyte solutions (SSF, SGF, SIF) to 37°C prior to using 547 
them in the digestion procedures. 548 
  549 
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Procedure 550 
Preparation reagents and digestion tubes (5 days):  551 
1. Perform all enzyme and bile assays (Box 1) according to the protocols in the 552 
Supplementary Information for each new batch of enzymes or after prolonged storage; 553 
TIMING 4-5 days for all assays 554 
Critical Step: For the pepsin assay, dissolve pepsin in 10 mM Tris, 150 mM NaCl, pH 555 
6.5, which improves the reproducibility of the assay (see Supplementary Information). 556 
Critical Step: Spreadsheets for the enzyme assays and the volumes for the digestion 557 
procedure are provided in the Supplementary Information of this manuscript 558 
(Supplementary spreadsheets 1 and 2). In addition, the corresponding online 559 
spreadsheets are available here: www.proteomics.ch/IVD and on the INFOGEST website 560 
https://www.cost-infogest.eu/.  561 
Critical Step: Prepare one tube per time point and food; e.g. for one food and six time 562 
points, prepare six tubes 563 
2. Pre-warm the electrolyte stock solutions at 37°C, initially only SSF and SGF, SIF 564 
3. Prepare all enzyme and bile solutions immediately before the digestion experiment 565 
Critical Step: Keep all enzyme solutions on ice 566 
4. In order to perform more efficient pH adjustments during the digestive phases, prepare 567 
one replicate tube (pH-test adjustment experiment) with the relevant amount of food, 568 
enzymes and bile for the entire digestion process (time-lagged before the digestion 569 
experiment or one day prior to the digestion experiment) and measure and record the 570 
volumes of HCl and NaOH used to reach the target pH. These volumes are indicative of 571 
the necessary volume of acids and bases needed for the gastric and intestinal phase 572 
TIMING 5h 573 
5. Optional: Prepare one replicate test as a food stability control to assess the behaviour of 574 
the food during exposure to simulated digestive fluids without enzymes or bile, for 575 
example after oral, gastric and intestinal phase 576 
6. Prepare one replicate test tube as a blank, digestion without food (replaced by water) but 577 
with all required enzymes and bile. See videos of enzyme assays (supplementary videos 578 
3 to 7) as well as the digestion procedures (supplementary videos 3 and 4). Videos are 579 
also available online on the YouTube channel “In vitro food digestion - COST action 580 
INFOGEST” https://www.youtube.com/channel/UCdc-NPx9kTDGyH_kZCgpQWg  581 
and on the INFOGEST website https://www.cost-infogest.eu/  582 
 583 
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Digestion procedure 584 
TIMING depending on number of food samples and time points, for example:1 food sample 585 
and 5 time points - approximately 5h; 2 food samples and 5 time points (2 gastric and 3 586 
intestinal points) - approximately 8h 587 
Oral phase (30 min) 588 
7.  Dilute food with SSF at a ratio of 1:1 (w/w) to achieve a swallowable bolus with a paste-589 
like consistency similar to that of tomato paste or mustard at the end of the oral phase. If 590 
the consistency of the bolus is thicker than paste-like, add water to achieve it. Salivary 591 
amylase is only needed to digest starch containing food. It can be omitted if the food 592 
does not contain starch. Do not use lower purity salivary amylase or pancreatic amylase. 593 
8. Mix food with SSF at a 1:1 ratio (w/w), e.g. 5 g of food to 5 g of SSF 594 
9. Measure the volume of the final digestion mixture of the food + SSF mixture. Record this 595 
volume as it will be used in step 17. 596 
10. If necessary, simulate mastication by mincing the food in an electric or manual mincer. 597 
11. Depending on the food (e.g. bread), mincing can be done together with the SSF 598 
electrolyte (without enzymes) 599 
12. Add SSF electrolyte stock solution to the food, if not done in the previous step 600 
13. Add CaCl2 in order to achieve a total concentration of 1.5 mM in SSF 601 
14. Add the salivary amylase, if necessary, prepared in water to achieve an activity of 75 602 
U/mL in the final mixture. 603 
15. Add the remaining water in order to achieve 1× concentration of the SSF. 604 
16. Incubate while mixing for 2 minutes at 37°C. 605 
Critical step: Electrolyte concentrations are given for the simulated digestive fluids 606 
(SSF, SGF and SIF) and accumulation in consecutive digestion phases is not 607 
considered whereas enzyme activities are expressed U/mL in the final digestion mixture. 608 
 609 
Gastric phase (3h)  610 
17. Pre-warm the SGF electrolyte stock solution at 37ºC. Add SGF electrolyte stock solution 611 
to the oral bolus to a final ratio of 1:1 (v/v)  612 
18. Adjust the pH to 3.0 by adding a defined volume of HCl previously determined during a 613 
pH-test adjustment experiment, see Experimental Design 614 
Critical step: For solid food, the pH changes are generally slower in response to the 615 
addition of HCl – it is important to remain patient and wait until the pH is stable, usually, 616 
this takes >5 min depending on food particle size and buffering capacity. 617 
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19. Add CaCl2 solution in order to achieve a final concentration of 0.15 mM in SGF. 618 
20. Add the porcine pepsin solution prepared in water to achieve an activity of 2,000 U/mL in 619 
the final digestion mixture. 620 
21. Add the gastric lipase solution prepared in water to achieve an activity of 60 U/mL in the 621 
final digestion mixture. 622 
22. Verify the pH and adjust to 3.0 if necessary  623 
23. Add water in order to achieve 1×concentration of the SGF  624 
24. Incubate the samples at 37°C, mixing the digestive mixture sufficiently (e.g. rotating 625 
wheel, shaking incubator) for 2 h from the point when pepsin was added. In case of large 626 
precipitates and formation of clogs, see Troubleshooting. 627 
Critical step: Rabbit gastric extracts (RGE) contains both gastric lipase and pepsin67. 628 
The pepsin activity in RGE needs to be determined and taken into account together with 629 
the porcine pepsin to reach a combined pepsin activity of 2,000 U/mL in the final 630 
digestion mixture. 631 
Critical step: The use of carbonate salts in the electrolyte solutions requires that sealed 632 
containers with limited headspace are used. In open vessels, CO2 will be release and 633 
the pH will progressively increase with time. If open vessels are to be used, such as 634 
when using the “pH-stat” approach or for sampling purposes, it is suggested to replace 635 
sodium bicarbonate (NaHCO3), the main source of carbonates, by NaCl at the same 636 
molar ratio in order to maintain the ionic strength of the electrolyte solutions (oral, gastric 637 
and intestinal). Such adjustment has already proven effective in avoiding unwanted pH 638 
drift in open vessels in both gastric69 and intestinal42 phases of digestion (see Table 2). 639 
 640 
Intestinal phase (3h):  641 
25. Pre-warm the SIF electrolyte stock solution in a 37ºC water bath. Add SIF electrolyte to 642 
the gastric chyme and achieve a final ratio of 1:1 (v/v). 643 
26. Adjust to pH 7.0 by adding a defined volume of NaOH previously determined during a 644 
pH-test adjustment experiment, see Experimental Design. 645 
Critical step: For solid food, the pH changes are slower in response to the addition of 646 
NaOH, see remarks in step 18; this may take several minutes. 647 
27. Add the bile solution to the SIF: gastric chime solution in order to reach a final 648 
concentration of 10 mM. Place the solution in a rotating wheel mixer at 37°C for at least 649 
30 min to achieve complete bile solubilisation. 650 
28. Add CaCl2 solution in order to reach concentration of 0.6 mM in SIF.  651 
29. Perform intestinal phase with option (A) pancreatin or option (B) with individual enzymes 652 
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A.  653 
i. Add the pancreatin suspension in SIF solution to achieve a trypsin activity 654 
of 100 U/mL in the final mixture. Additional pancreatic lipase may be 655 
needed for the digestion of fat containing food to reach the required lipase 656 
activity to achieve a lipase activity of 2,000 U/mL in the final mixture. 657 
Critical step: Measure trypsin activity in pancreatic lipase powder and subtract it 658 
from the needed trypsin activity  659 
B.  660 
i. Add trypsin, chymotrypsin, pancreatic α-amylase, pancreatic lipase and 661 
the co-lipase solutions in SIF, in order to reach 100, 25, 200 and 2,000 662 
U/mL, respectively, in the final digestion mixture  663 
30. Verify the pH and adjust to 7.0 if necessary  664 
31. Add water in order to achieve 1×concentration of the SIF  665 
32. Incubate the samples at 37°C, mixing the digestive mixture sufficiently using a rotating 666 
wheel or shaking incubator for 2h starting at the point when pancreatic enzymes were 667 
added. For difficulties with sampling, see Table 4 Troubleshooting. 668 
Critical step: If open vessels are used (“pH-stat” approach), NaHCO3 should be 669 
replaced by NaCl in the electrolyte solutions to avoid unwanted pH drift (see the step 24 670 
critical step). 671 
  672 
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Anticipated Results 673 
Protein digestion 674 
Without the use of standardised digestion methods, the main difficulties were (i) the absence 675 
of comparable results from different laboratories and (ii) the physiological relevance of 676 
experimental data in the field of food digestion. The INFOGEST method was tested with 677 
respect to these two aspects focusing on protein digestion. 678 
(i) Robustness of the protocol and comparability of experimental data were assessed in 679 
several inter-laboratory trials where the participants were asked to digest a standardised 680 
skim milk powder (SMP) by applying their existing in-house protocols first, then by using the 681 
harmonised protocol28. The first critical step in protein hydrolysis is the pepsin activity in the 682 
gastric phase. The heterogeneous pattern observed with the in-house digestion protocols 683 
(Figure 2a, gastric phase) was improved significantly by the correct implementation of the 684 
harmonised protocol (Figure 2b, gastric phase), except for laboratories 6 and 7, which 685 
showed incomplete casein hydrolysis.  Adjustments in the pepsin assay (addition of Tris 686 
buffer, see Step 1 Critical Step and Box 1) improved the reproducibility and reduced lab-to-687 
lab variability28. This improved pepsin assay is now recommended for the INFOGEST 2.0 688 
method. Figure 2b shows improved homogeneity between samples, compared to the gastric 689 
phase when the harmonised protocol was applied. Increased protein degradation in the 690 
intestinal phase was observed in laboratories 4 and 7. Subsequent recommendation on the 691 
correct sample preparation, in particular the correct inhibition of enzymes at the end of the 692 
digestion experiment (see Table 1), improved lab-to-lab variability28. 693 
 (ii) Physiological relevance was evaluated by comparing in vitro SMP digestion with that of 694 
an in vivo pig trial 29. Pigs were fed reconstituted SMP from the same batch as applied in the 695 
in vitro tests and samples were collected from the stomach and in several sections of the 696 
small intestine (jejunum, I1- I3 to ileum, I4) after sacrifice. Milk peptides were identified with 697 
mass spectrometry and overall peptide patterns were visualised by summing up the number 698 
of times each individual amino acid was identified within a milk peptide. Overlay of the 699 
average peptide patterns for αs2-casein from the harmonised in vitro digestion (n=7) and in 700 
vivo pig digestion (n=8) showed that at the end of the gastric phase, the peptide pattern 701 
corresponded well to that of the pig sample collected from the stomach; the peptide pattern 702 
in the in vitro intestinal phase sample was most similar to that of the pig sample collected in 703 
the median jejunum (I3). This comparison showed that protein hydrolysis at the endpoints of 704 
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the harmonised INFOGEST digestion method were in agreement with that of the in vivo 705 
digestion (Figure 3).  706 
In conclusion, both critical points, inter-laboratory comparability and physiological relevance 707 
were improved by the correct application of the harmonised in vitro digestion protocol. 708 
  709 
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 710 
Lipid Digestion 711 
To date, most published digestion experiments using this INFOGEST method did not include 712 
a gastric lipase because of the lack of commercially available, acceptable substitutes for 713 
human gastric lipase (HGL). This situation has changed with the availability of rabbit gastric 714 
extracts containing gastric lipase, see Experimental Design in the Introduction: Use of lipase 715 
in the gastric phase. Both HGL and rabbit gastric lipases exhibit, at the recommended gastric 716 
pH of 3.0, approximately 50% of their maximum activity measured at pH 4 to 5.4 70,71. 717 
Moreover, the in vitro gastric lipolysis of infant formula by rabbit gastric lipase were 718 
consistent with in vivo data, with a degree of lipolysis reaching 10% after 60 min of gastric 719 
digestion72. These data therefore suggest that gastric lipolysis could be studied using this 720 
INFOGEST 2.0 method with rabbit gastric extract as a source of gastric lipase64 or human 721 
gastric lipase if available61. 722 
The INFOGEST method has also been used to study intestinal lipid digestion, for example in 723 
oil-in-water emulsions stabilised by milk or soya lecithin73. However, human gastric analogue 724 
and phospholipases A2 (PLA2) were added in this procedure. The degree of hydrolysis (% 725 
TAG disappearance) ranged between 73 and 87 % (± 5 %) at the end of the intestinal phase 726 
(120 min). In addition, in vitro digestion was also performed with more complex systems such 727 
as whole fat dairy products or protein/polysaccharide emulsions. Depending on the structure 728 
of the food matrix and the state of dispersion of the lipids, the reported degrees of hydrolysis 729 
at the end of the intestinal phase ranged from moderate (66% of remaining lipids in poorly 730 
digestible raw oat flakes due to limiting matrix structure)74 to an almost complete 731 
disappearance of triglycerides75.  732 
Intestinal lipid digestion can be assessed by chemical analyses of collected samples. The 733 
protocol recommends analysing the entire volume of digestive tubes to prevent sampling 734 
errors (see Procedure Step 1 Critical Step, one tube per time point and food). This 735 
precaution is particularly useful in the presence of lipids74 as they often tend to destabilise 736 
and phase-separate (cream) during the gastric and/or intestinal phases of digestion. If 737 
aliquots are taken as sample points, great care should be taken to represent the whole 738 
digested solution. The best way to analyse the extent of lipolysis is to conduct the Folch 739 
extractions76 on the samples in the presence of internal standards before the analysis of 740 
classes of the lipids (residual triglycerides, free fatty acids, diglycerides and monoglycerides) 741 
by thin layer chromatography combined with densitometry or gas chromatography with a 742 
flame ionization detector (GC-FID)77 or HPLC coupled to a light scattering detector 78. Free 743 
fatty acids can also be quantified after solid phase extraction with GC-FID, using fatty acids 744 
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(typically C11:0, C15:0, C17:0 or C23:0) as internal standards 72,79. The pH-stat method, one 745 
of the most commonly used methods for monitoring pancreatic lipolysis, can also be used, 746 
but three sources of errors should be taken into consideration: (i) the pH-stat measurements 747 
can be impaired by the high concentrations of carbonate salts, recommended for the 748 
simulated digestion fluids (see the step 24 critical step It is therefore advised to replace 749 
NaHCO3 salts with NaCl at the same molarity in all electrolyte solutions (oral, gastric and 750 
intestinal) when planning to use pH-stat experiments during the intestinal phase of 751 
digestion42; (ii) protein hydrolysis also contributes to the pH-stat signal in the intestinal 752 
conditions (pH = 7), meaning that this approach is only suitable for studying pancreatic 753 
lipolysis when the contribution of proteins is either neglected or sustracted42; (iii) some fatty 754 
acids, especially long chain fatty acids, are not ionised at pH7. A back titration at pH 9.0 755 
should be performed to measure all the free fatty acids released80. 756 
 757 
Digestion of starch 758 
The structure of starch in a ready-to-eat plant-based food is a function of a multitude of 759 
factors. These include its botanical origin, growing conditions, processing, food preparation 760 
(mainly cooking), and not least storage. These all have a major impact on salivary and 761 
pancreatic amylase catalysed starch digestion. The rate of the loss of starch and the 762 
appearance of the digestion product (maltose and maltooligosaccharides) are the most 763 
common measures of in vitro starch digestibility. To help in the understanding of the 764 
physiological effects of starch digestion such as on glycaemic response in humans, 765 
measurements should also include (i) the accurate dose and nature of the starch in the food 766 
as eaten, (ii) the characterisation of the food matrix (microstructure, macro and micronutrient 767 
composition) and (iii) a measure of the degree of starch gelatinisation and/or retrogradation.  768 
It is recommended that starch amylolysis is quantified only in the intestinal phase by 769 
measuring the appearance of the starch digestion products over time, e.g. the concentration 770 
of reducing sugars in the liquid phase. Salivary amylase will have a minor impact on starch 771 
digestion in the static model were the gastric pH is instantaneously adjusted to 3. After 772 
terminating amylase activity by mixing the sample with 4 volumes of ethanol (final conc. 80% 773 
w/v) to the sample, for example (see different options in Table 1), undigested starch is often 774 
separated from digested starch by centrifugation. Analysis of reducing sugar concentration in 775 
the supernatant is often done with common colorimetric assays (e.g. using DNS or PAHBAH 776 
(4-Hydroxybenzhydrazide) reagents). Another more common method is to treat an aliquot of 777 
the amylase digestion products from the 80% w/v ethanol supernatant with buffered 778 
amyloglucosidase to convert all amylase digestion products to glucose. Glucose can then be 779 
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determined through a whole host of methods including colorimetric and enzymatic assays (e. 780 
g. GOPOD) or by direct chromatography analysis to name just a few. The data collected can 781 
then be used as input variables to a wide variety of simple to complex kinetic-based 782 
mathematical models that seek to quantify starch digestion and give predictions on the 783 
physiological effects of the food under. 784 
 785 
Bioaccessibility of phytochemicals 786 
The main challenges for investigating common dietary phytochemicals such as hydrophilic 787 
polyphenols and hydrophobic carotenoids are: i) the physiological appropriateness of the 788 
digestion conditions, such as reproducible matrix-release and the sufficient presence of 789 
enzymes required for cleavage and cellular uptake and ii) separating the bioaccessible 790 
phase from unavailable phytochemicals (e.g. precipitated or in complexed form), which can 791 
be achieved by centrifugation and/or filtration/dialysis. 792 
(i) Physiological appropriateness and pitfalls: Good correlations between bioaccessibility and 793 
in vivo bioavailability have been obtained for certain phytochemicals, such as 794 
carotenoids81,82. However, slight alterations of the digestion parameters suggested by the 795 
original INFOGEST method27 can drastically influence bioaccessibility. For instance, 796 
increasing the amount of pancreatin and/or bile83 or increasing the speed of shaking/stirring 797 
can considerably enhance the bioaccessibility of carotenoids by improving mixing, disrupting 798 
oil droplets and increasing micellisation. Thus, careful consideration and the possible further 799 
standardisation of these parameters are vital. Additional important factors to consider are 800 
light and oxygen, as they can result in the oxidative degradation of carotenoids 84 and 801 
polyphenols 85 and polymerisation of the latter 86. It is recommended to flush samples with Ar 802 
or N2 for a few minutes prior to small intestinal digestion to remove oxygen 
82,87 or to use 803 
pyrogallol. However, the latter is unsuitable for polyphenolic samples as this is a potential 804 
metabolite. Another often neglected factor is the potential effect of brush border membrane 805 
enzymes (e.g. lactase-phlorizin-hydrolase) on phytochemical bioaccessibility, especially for 806 
polyphenols88,89. The inclusion of brush border membranes (BBM) vesicles in in vitro 807 
gastrointestinal digestion may increase the physiological relevance of the model, especially 808 
for polyphenols 90. However, BBM are not commercially available nor is there any standard 809 
method available to date. 810 
(ii) Bioaccessible phase and pitfalls: For polyphenols, dialysis is often performed to remove 811 
macromolecular-bound compounds91, but for carotenoids a combination of centrifugation 812 
(e.g. 4,000×g for at least 30 minutes) and a filtration step (0.2 µm) has become the most 813 
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widely used method31 to separate the bioaccessible aqueous phase from larger lipid droplets 814 
or crystals that would not be taken up by the enterocytes.  815 
When combining in vitro digestion with cellular assays (e.g. cellular uptake/transport), the 816 
toxicity of the bile salts must be accounted for, by including a clean-up step, e.g. solid phase 817 
extraction 92-94, or at least the sufficient dilution of samples (e.g. 4× dilution). 818 
Finally, it should be considered that the colon may play an important role for the bioavailable 819 
fraction. While it is well known that polyphenols can undergo many changes in the colon 88, 820 
and may be absorbable in the colon, little is known for carotenoids, though a significant 821 
fraction would be bioaccessible in the colon 95. 822 
On-going developments and future perspectives for in vitro food digestion 823 
The establishment of the INFOGEST digestion protocol is a good starting point in the 824 
standardisation and harmonisation of food digestion methods. Henceforth, results from 825 
different research groups can be compared in a meaningful manner. However, users have to 826 
be aware of the shortcomings of this method and considerable efforts are being made 827 
around the world to improve or add to the existing method.  828 
The INFOGEST method is for adult digestion only. However, there is a strong need to apply 829 
this method to specific human population groups, the most important being infants and the 830 
elderly, but also adolescents and patients with cystic fibrosis or gastric bypass surgery, to 831 
name but a few. A recent review96 summarised the existing literature and provides some 832 
recommendations on experimental digestion parameters, with the INFOGEST method being 833 
the starting point for all other methods.  834 
While static methods can be useful, they can be inadequate to simulate the dynamic 835 
processes during digestion (e.g. pH gradients, gradual addition of enzymes and gastric fluid, 836 
continuous gastric emptying, etc.). As mentioned earlier, various dynamic digestion 837 
methods6-10 account for some of these factors. A low-cost semi-dynamic method was recently 838 
developed49 and described in detail50, based on equivalent in vivo data from the digestion of 839 
dairy products. International INFOGEST members are currently working on a consensus 840 
method. 841 
Enzymes from the small intestinal brush border membranes are recognised as playing a 842 
major role in the activation of trypsinogen (enterokinase) and the further degradation of 843 
proteins/peptides and carbohydrates as well as improving the bioaccessibility of 844 
phytochemicals. The use of brush border enzymes falls into the grey area between 845 
bioaccessibility (potentially absorbable) and bioavailability (available at the site of action) and 846 
to date, it is not clear how they should be applied. BBM of animal origin have recently been 847 
included in static digestion methods39,97,98 and can provide physiologically consistent 848 
information99. However, to date BBM enzymes are not commercially available and are 849 
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extracted from fresh animal intestines100 or used as intestinal extracts. There is still a lack of 850 
reliable information on the correct enzymatic activities, enzyme substrate ratio and diversity 851 
of enzymes, which further limits the use of BBM in standardised digestion methods at the 852 
moment. However, given the importance of BBM in the digestive process, further progress in 853 
terms of defining digestive parameters is anticipated. 854 
 855 
TIMING 856 
Step 1, enzyme activity and bile assays: 4 to 5 days for all assays 857 
Steps 2 and 3, preparation of solutions: 2 hours 858 
Step 4, pH-adjustment experiment: 5 hours (time-lagged before the digestion experiment) 859 
Steps 5 and 6, preparation of replicate tests as control: 20 min 860 
Steps 7 to 32, whole digestion experiment: 5 to 8 hours, depending on number of food 861 
samples and time points, for example:1 food sample and 5 time points - approximately 5h; 2 862 
food samples and 5 time points (2 gastric and 3 intestinal points) - approximately 8h 863 
Steps 7 to 16, oral phase: 30 min 864 
Steps 17 to 24, gastric phase: 3 hours 865 
Steps 25 to 32, intestinal phase: 3 hours 866 
 867 
 868 
 869 
TROUBLESHOOTING 870 
Troubleshooting advice can be found in Table 4. 871 
 872 
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Figures  1007 
 1008 
Figure 1: Flow diagram of the INFOGEST 2.0 digestion method 1009 
Timing and flow diagram of the INFOGEST2.0 in vitro digestion method for food. SSF, SGF 1010 
and SIF stand for simulated salivary, gastric and intestinal fluid, respectively. Expected time 1011 
frame (left) and steps (right) corresponding to the step numbers in the Procedure section. 1012 
  1013 
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 1014 
Figure 2: Protein separation by gel electrophoresis of in vitro digested skim milk 1015 
powder (SMP) 1016 
Comparing results from in-house protocols performed in individual laboratories 1-12 (a), with 1017 
the harmonised protocol, performed in 7 different laboratories (b) after the gastric and the 1018 
intestinal phase of in vitro digestion. Undigested skim milk powder (SMP) is shown as a 1019 
control, specific protein bands are highlighted with arrows: casein fragments, partly 1020 
hydrolysed casein; pancreatin, bands originating from pancreatin. Figure adapted from Egger 1021 
et al.28 1022 
  1023 
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 1024 
 1025 
Figure 3: Comparison of in vitro digested skim milk powder (SMP) peptide patterns of 1026 
-casein with in vivo (pig) digestion 1027 
(a) Gastric in vitro digestion samples (in vitro S) were compared to gastric pig samples (pig 1028 
S, n = 8, as previously published by Egger et al.29, approval number 2015_04_FR;26115). (b) 1029 
Intestinal in vitro digestion samples were compared to pig sampling sections collected along 1030 
the digestive tube from duodenum (D), proximal- (I1), median- (I2), distal jejunum (I3), and to 1031 
ileum (I4)29. The x-axis shows the amino acid (AA) sequence of -casein and the y-axis 1032 
shows the number of times each amino acid was identified within a  -casein peptide of ≥ 5 1033 
AA in length. 1034 
 1035 
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TABLES 1395 
 1396 
Table 1: Examples for the preservation and treatment of samples after in vitro digestion  1397 
Application Objectives Method Description Sample preparation Ref. 
Food  
structure 
Microscopy 
Rheology 
Particle size  
 
 
 
Keep on ice and perform 
microscopy observations 
immediately after sampling 
Fresh samples for standard 
microscopy sample preparation 
(e.g. resin embedding, chemical 
fixation, drying).  
74,101 
Breakdown of 
nutrients: 
Proteins 
Protein hydrolysis 
or resistant protein 
analysis 
Stop gastric 
digestion 
(2 options) 
 
Raise the pH to 7 for partial 
inactivation of pepsin; pH 8 
for complete inactivation.  
Addition of 1 M NaHCO3 or 1N 
NaOH  
28 
Addition of pepstatin A for 
pepsin inhibition. 
Add Pepstatin A at 0.5-1.0 µM 
final concentration. 
102 
 
Stop intestinal 
digestion 
(3 options) 
Addition of Pefabloc® SC (4-
(2-aminoethyl)-
benzolsulfonylfluorid-
hydrochloride) for serine 
protease (trypsin and 
Add 50 µl of Pefabloc (0.1 M) in 
water per mL of intestinal digesta. 
(5 mM final concentration). 
28  
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 chymotrypsin) inhibition. 
Addition of Bowman-Birk 
inhibitor (BBI) from soybean 
with ability to inhibit both 
trypsin and chymotrypsin. 
Add 100µl of a BBI solution 0.05 
g/L in water per mL of intestinal 
digesta. 
103 
 
Heat shock treatment Sample treatment: 100°C, 5 min, 
but detrimental to food structure, 
especially protein and 
carbohydrate structures 
41 
Breakdown of 
nutrients: Lipids 
Lipid hydrolysis  Stop lipase 
activity in the 
gastric phase 
(2 options) 
Addition of Orlistat 
(tetrahydrolipstatin)  
Add 10 µL/mL of a 100 mM 
Orlistat solution in ethanol (1 mM 
final concentration) 
104 
Raise the pH to 8  59 
Stop lipase 
activity in the 
intestinal phase 
(2 options) 
Addition of lipase inhibitor (4-
bromophenylboronic acid) 
Add 5 µL/mL of a 1 M solution of 
4-bromophenylboronic acid in 
methanol to 1 mL of digesta (5 
mM final concentration). 
105 
Addition of 
methanol:chloroform 
Addition of methanol: chloroform 
mixture used for Folch extraction 
76 
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Breakdown of 
nutrients: 
Carbohydrates 
Starch hydrolysis Stop amylase 
activity 
(4 options) 
Addition of NaCO3 Dilute digesta in 2 volumes of 0.3 
M NaCO3 
106 
Heat shock treatment 100°C for 5 min   
TCA precipitation Add 700 µL of 100% TCA to 5 mL 
digesta 
107 
Ethanol Add sample to equal volume of 
ethanol 
108 
Breakdown of 
oxygen 
sensitive 
phytochemicals 
Degradation of 
polyphenols and 
carotenoids 
Prevent contact 
with Oxygen 
Flushing with Ar or N2, 
pyrogallol addition 
(carotenoids) prior to small 
intestinal digestion 
Flush sample 1 minute with Ar or 
N2 
87 
Bioaccessibility Bioaccessibility of 
digested nutrients 
Stop pancreatic 
activities (see 
above Stop 
intestinal 
digestion) 
Use of inhibitors e.g. 
Pefabloc. Test whether the 
use of enzyme inhibitors 
affect the results of the 
experiment. 
See above Stop intestinal 
digestion 
28 
Use of dialysis membranes/ 
centrifugation tubes having 
 109 
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cut-off of 3 to 10kDa. 
To dilute the digested 
samples to maintain the 
epithelium integrity of cell 
monolayers and avoid 
cytotoxicity 
Dilution (several folds) of digested 
samples to reach osmolarity 
values at physiological level (285-
300 mOsm/kg H2O). 
110,111 
Extraction of compounds by 
using either solvents or acidic 
solutions 
Different procedures for a wide 
range of compounds are 
employed 
112 
Bioaccessibility of 
digested 
phytochemicals 
 Removal of unavailable 
constituents such as bound 
to macromolecules or 
complexed form 
Ultracentrifugation and filtration 
with certain cut-off filters (e.g. 0.2 
µm) 
110 
Cleavage of glucosides and 
esters 
Addition of brush border vesicles 90 
Probiotic 
survival 
To determine the 
survival rates of 
probiotic bacteria to 
digestion conditions 
 Immediate use of samples 
after digestion  
 
To serially dilute the digested 
samples and plate for bacterial 
growth 
113 
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Colonic 
fermentation 
and modulation 
of intestinal 
microbiota 
Biotransformation of 
compounds and 
their effects on 
bacterial growth 
Stop enzymatic 
activities 
By heat shock  Heat treatment: 100 °C for 5 min 
but detrimental to food structure, 
especially protein and 
carbohydrate structures 
114 
Immediate storage in ice 
before batch culture 
fermentation 
 115 
 1398 
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 1399 
Table 2: Volumes of electrolyte stock solutions of digestion fluids for a volume of 400 mL 1400 
diluted with water (1.25× concentrations).  1401 
  SSF (pH 7) SGF (pH 3) SIF (pH 7) 
Salt solution 
added 
Stock 
concentrations 
mL of 
Stock 
added to 
prepare  
0.4 L 
(1.25x) 
Final 
salt 
conc. in 
SSF 
mL of 
Stock 
added to 
prepare  
0.4 L 
(1.25x) 
Final 
salt 
conc. in 
SGF 
mL of 
Stock 
added to 
prepare  
0.4 L 
(1.25x) 
Final 
salt 
conc. in 
SIF 
g/L M mL mM mL  mM mL  mM 
KCl 37.3 0.5 15.1 15.1 6.9 6.9 6.8 6.8  
KH2PO4 68 0.5 3.7  3.7 0.9 0.9 0.8 0.8  
NaHCO3* 84 1 6.8 13.6 12.5 25 42.5 85 
NaCl 117 2 - - 11.8 47.2 9.6 38.4 
MgCl2(H2O)6 30.5 0.15 0.5 0.15 0.4 0.12 1.1 0.33  
(NH4)2CO3 * 48 0.5 0.06 0.06 0.5 0.5 - - 
HCl   6 0.09 1.1 1.3 15.6 0.7 8.4 
Addition before use (volumes are indicated in Table 3, typical experiment of 5 mL of SSF): 
CaCl2(H2O)2 44.1 0.3  0.025 1.5 0.005  0.15 0.04  0.6  
 1402 
  1403 
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Table 3: Example of an in vitro digestion experiment with 5 g of food  1404 
Input 5 g of liquid or solid food 
Digestion phase Oral (SSF) Gastric (SGF) Intestinal (SIF) 
Food or digesta 5 g of food 
10 mL from oral 
phase 
20 mL from gastric phase 
1.25× electrolyte stock 
solutions (mL) 
4 8 8** 
CaCl2  (0.3 M) (mL) 0.025 0.005 0.04 
Enzymes Salivary amylase Pepsin 
Gastric
#
 
Lipase  
Trypsin in 
pancreatin 
Bile salts 
Enzyme activity (U/mL) 
or bile conc. (mM) in 
total digesta (final 
volume in mL at each 
digestion phase, see row 
below) 
75 U/mL 
2,000 
U/mL 
60 
U/mL 
100 U/mL 10 mM 
Specific activity* (U/mg), 
Conc. (bile) mmole/g 
100 U/mg 
3,000 
U/mg 
25 
U/mg 
6 U/mg 0.667mmole/g 
Conc. of enzyme/bile 
solution (mg/mL) 
10 20 100 133.3 200 
Volume of enzyme/bile 
to be added (mL) 
0.75 0.667 0.48 5** 3** 
H2O (mL) 0.225 0.448 3.16 
HCl (5M) for pH adj. 
(mL) 
- 0.4 - 
NaOH (5M) for pH adj. 
(mL) 
- - 0.8 
Final volume (mL) 10 20 40 
Remarks - Use salivary amylase 
only for food 
containing starch - 1:1 
(w/w) dilution with SSF 
should result in a 
paste-like consistency, 
add more water if 
necessary 
- Some foods may not 
be digested as 
expected due to high 
substrate to enzyme 
#
Rabbit gastric 
extract (RGE) 
contains gastric 
lipase and 
pepsin, i.e. the 
pepsin content 
needs to be 
accounted for in 
the total pepsin 
activity 
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ratio in the static 
digestion method and 
may need to be further 
diluted with water prior 
the oral phase, see 
Table 4 
Troubleshooting 
*Specific enzyme activity or bile concentration: measured for each batch of enzymes or bile 1405 
extract according to standard assays (Supplemental Materials from Minekus et al. 27), the 1406 
enzyme assays for gastric lipase and pepsin are described in the supplemental materials of 1407 
this manuscript 1408 
**Total volume of SIF (1.25×): 16 mL including pancreatin and bile, both of which are 1409 
dissolved in SIF 1410 
  1411 
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Table 4: Troubleshooting  1412 
Procedure step 
(number) 
Problem Possible reason Solution 
Enzyme activity 
(1) 
Pepsin activity 
results in lower 
activity units than 
specified 
Enzyme activity 
measurement 
Follow the standardised 
procedure using 
haemoglobin as substrate. 
Dissolve pepsin in 10 mM 
Tris, 150 mM NaCl, pH 6.5 
 
Enzyme activity 
(1) 
Amylase activity 
very low 
DNS (3,5-
dinitrosalicylic acid ) 
does not react with 
product 
DNS solution needs to be 
freshly prepared 
 
 
 
Gastric phase 
(24) 
Food is not 
digested as 
expected. It forms 
a big clog and it is 
not digested at the 
end of the gastric 
phase 
Excessive amount of 
substrate 
Revise the amount of food 
introduced into the system. 
Realistic food consumption 
should be targeted. Dilute or 
suspend food in an 
appropriate amount of water, 
if necessary. 
For example, to mimic the 
porcine in vivo digestion of 
cheese 29 at the end of the 
gastric phase, the cheese 
has to be diluted with water 
at 1:2 (w/w) prior to the oral 
phase. 
 
Gastric phase 
(24) 
pH difficult to 
adjust during 
gastric digestion 
Quick pH drift during 
gastric phase 
Run a pH-test adjustment 
experiment with the same 
food to determine volumes 
and times for HCl addition 
 
Gastric/intestinal Difficulties taking a Presence of different Use individual sample tube 
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phase (24, 32) homogeneous 
sample during 
digestion 
phases (lipids, 
water, solids) 
for each time point rather 
than withdrawal of samples 
from the digestion vessel. 
 
Gastric/intestinal 
phase (24, 32) 
Poor mixing during 
digestion 
Tube shape, volume 
or shaking is 
insufficient 
Check the volume of the 
sample and the tube or vials 
to allow sufficient mixing of 
the sample. 
 
Intestinal phase 
(32) 
Intestinal samples 
affect cell viability 
in cell culture 
studies 
Presence of bile 
salts, enzyme 
inhibitors 
Avoid the use of enzyme 
inhibitors to stop the 
digestion reaction. Reduce 
the bile salt concentration 
during the intestinal phase. 
Sufficiently dilute the 
digestion mixture. 
 
Intestinal phase 
(32) 
Presence of 
insoluble material 
at the end of the 
intestinal phase 
Non-digestible 
material 
Use individual sample tube 
for each time point 
 
 
Intestinal phase 
(32) 
Poor lipid digestion 
at the end of 
digestion 
Food contains high 
amount of lipids 
Add porcine pancreatic 
lipase and colipase to 
achieve 2,000 U/mL lipase 
activity in the final mixture. 
Consider additional trypsin 
activity present in the 
pancreatic lipase. 
 
Intestinal phase 
(32) 
Starch digestion is 
too low 
Incorrect method 
for quantification of 
starch digestion 
products 
Add amyloglucosidase to 
samples before measuring 
glucose OR use a reducing 
sugar assay to measure 
starch digestion products. 
Check activity of amylase. 
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 1413 
  1414 
Intestinal phase 
(32) 
Starch digestion 
product 
concentration does 
not change over 
time  
Starch digestion is 
finished before 
samples are 
collected.  
Take more samples at earlier 
time points. Consider using 
less amylase to slow the 
reaction down. Check 
feasibility of results by 
expressing findings as % of 
starch digested. 
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 1415 
Supplementary information 1416 
The Supplementary Information (SI) consists of: 1417 
1. Supplementary Figure 1 1418 
2. Supplementary Methods: protocols of enzyme assays 1419 
3. Supplementary videos 1420 
4. Supplementary spreadsheets in Excel format 1421 
 1422 
Supplementary Figure 1: Oral bolus hydration in vivo  1423 
Bolus hydration (g of saliva / g of foods) in vivo just before swallowing, for various foods 1424 
based on published data116-123 1425 
 1426 
Supplementary Methods 1427 
Protocols of enzyme activity assays (summarised in Box 1) for α-amylase (EC 3.2.1.1), 1428 
pepsin (EC 3.4.23.1), gastric lipase (EC 3.1.1.3), trypsin (EC 3.4.21.4), chymotrypsin (EC 1429 
3.4.21.1), pancreatic lipase (EC 3.1.1.3) and bile salts (according to supplier´s protocol) 1430 
 1431 
Supplementary Videos:  1432 
Supplementary Video 1  1433 
INFOGEST 2.0 digestion procedure part 1  1434 
Supplementary Video 2  1435 
INFOGEST 2.0 digestion procedure part 2  1436 
Supplementary Video 3 1437 
Amylase activity assay  1438 
Supplementary Video 4 1439 
Pepsin activity assay  1440 
Supplementary Video 5 1441 
Lipase activity assay (both gastric and pancreatic) 1442 
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Supplementary Video 6 1443 
Trypsin activity assay  1444 
Supplementary Video 7 1445 
Chymotrypsin activity assay 1446 
 1447 
Supplementary spreadsheets  1448 
Supplementary spreadsheets 1 1449 
Excel spreadsheets to calculate the enzyme activities of all digestive 1450 
enzymes. 1451 
Supplementary spreadsheets 2 1452 
Excel spreadsheets to calculate all volumes of simulated digestive fluids, 1453 
enzyme and bile solutions based on the initial amount of digested food.  1454 
In addition, the corresponding online spreadsheets and videos of the enzyme assays and 1455 
digestion procedures are available here: www.proteomics.ch/IVD and on the INFOGEST 1456 
website https://www.cost-infogest.eu/.  1457 
 1458 
  1459 
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Supplementary Figure 1 
Oral bolus hydration in vivo 
Bolus hydration (g of saliva / g of foods) in vivo just before swallowing, for various foods based on published data
1-8
 
References 
1 Watanabe, S. & Dawes, C. The effects of different foods and concentrations of citric acid on the flow rate of whole saliva in 
man. Arch. Oral Biol. 33, 1-5, doi: 10.1016/0003-9969(88)90089-1 (1988). 
2 St-Eve, A., Panouille, M., Capitaine, C., Deleris, I. & Souchon, I. Dynamic aspects of texture perception during cheese 
consumption and relationship with bolus properties. Food Hydrocolloids 46, 144-152, doi: 10.1016/j.foodhyd.2014.12.015 
(2015). 
3 Motoi, L., Morgenstern, M. P., Hedderley, D. I., Wilson, A. J. & Balita, S. Bolus moisture content of solid foods during 
mastication. J. Texture Stud. 44, 468-479, doi: 10.1111/jtxs.12036 (2013). 
4 Moongngarm, A., Bronlund, J., Grigg, N. & Sriwai, N. Chewing behavior and Bolus Properties as Affected by Different Rice 
Types. Vol. 6 (2012). 
5 Loret, C. et al. Physical and related sensory properties of a swallowable bolus. Physiol. Behav. 104, 855-864, doi: 
10.1016/j.physbeh.2011.05.014 (2011). 
6 Jourdren, S. et al. Breakdown pathways during oral processing of different breads: impact of crumb and crust structures. Food 
& Function 7, 1446-1457, doi: 10.1039/c5fo01286d (2016). 
7 Drago, S. R. et al. Relationships between saliva and food bolus properties from model dairy products. Food Hydrocolloids 25, 
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 1461 
Supplementary Methods - Enzyme assays 1462 
Enzyme and bile assays are adapted from Minekus et al.1, namely: α-amylase (EC 3.2.1.1), 1463 
pepsin (EC 3.4.23.1), trypsin (EC 3.4.21.4), chymotrypsin (EC 3.4.21.1), pancreatic lipase 1464 
(EC 3.1.13) and bile salts (according to supplier’s protocol). The assay for gastric lipase has 1465 
been adapted from Carrière et al.2 and merged with that for pancreatic lipase. 1466 
 1467 
-Amylase Activity Assay (EC 3.2.1.1) 1468 
References: according to Bernfeld3 1469 
Method: Spectrophotometric Stop Reaction 1470 
Principle:  1471 
Starch + H2O 
-Amylase> Reducing Groups (Maltose) 1472 
Unit definition: One unit releases 1.0 mg of maltose from (potato) starch in 3 minutes at pH 1473 
6.9 and 20°C. 1474 
Conditions: T = 20°C, pH = 6.9, A540nm, light path = 1 cm 1475 
Procedure 1476 
Preparation of reagents 1477 
Substrate: soluble potato starch (1.0% w/v) 1478 
Preparation of substrate solution: 1479 
Prepare 100 mL of a 20 mM sodium phosphate buffer containing 6.7 mM NaCl. Adjust the 1480 
pH to 6.9 at 20°C with 1 M NaOH. Dissolve 0.25 g soluble potato starch (ref S2630 Sigma-1481 
Aldrich) in 20 mL of the sodium phosphate buffer, pH 6.9. Heat the covered beaker while 1482 
stirring and maintain the solution just below boiling temperature for 15 minutes. Cool to room 1483 
temperature and complete the starch solution to the appropriate volume (25 mL) by addition 1484 
of H2O. 1485 
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Standard Curve: Prepare 10 mL of 0.2 % w/v maltose standard (M5885 Sigma-Aldrich). 1486 
Enzyme: Shortly before the assay, prepare an enzyme solution of an estimated activity of 1 1487 
unit/mL of -amylase in purified H2O  1488 
Assay solution: Colour reagent solution 3,5-dinitrosalicylic acid (DNS) 1489 
Prepare a 5.3 M sodium potassium tartrate solution in 2 M NaOH by dissolving 0.8 g NaOH 1490 
in 10 mL H2O and heating the solution at a temperature ranging between 50 to 70°C. Add 1491 
12.0 g of sodium potassium tartrate tetrahydrate (in 8.0 mL of warm 2 M NaOH solution, 1492 
maintain the temperature constant while stirring to dissolve the tartrate but do not boil it.  1493 
Prepare a 96 mM DNS solution by dissolving 438 mg of DNS in 20 mL of H2O. Heat the 1494 
solution at a temperature between 50 to 70°C. Maintain at this temperature while constant 1495 
stirring to dissolve DNS but do not boil it.  1496 
Heat 12 mL of purified water to 60°C and add slowly 8 mL of the 5.3 M the sodium potassium 1497 
tartrate solution. Add 20 mL of the 96 mM 3,5-dinitrosalicylic acid solution and stir until 1498 
complete dissolution. The solution can be stored in an amber flask at room temperature for 1499 
one month. 1500 
Assay: 1501 
Set the spectrophotometer at 540 nm and 20°C. Set a bench top shaking incubator fitted with 1502 
a sample holder at 20°C, a heating bath or block at 100°C to stop the reaction, and an ice-1503 
bath to cool the sample. 1504 
Test: Pipette 1 mL of substrate solution (potato starch) into cap covered tubes (15 mL), mix 1505 
and incubate at 20°C for 5 min to achieve temperature. Add 0.5 – 1 mL of enzyme solution 1506 
(according to the scheme below), mix and incubate at 20°C for exactly 3 minutes. 1507 
Immediately thereafter, stop the reaction by addition of 1 mL of DNS solution. Complete the 1508 
enzyme volume added to 1 mL, cap the tube, place it at 100°C (heating bath or block) and 1509 
boil it for exactly 15 minutes. Cool the tube for a few minutes on ice and add 9 mL of H2O. 1510 
Mix the reaction and pipette 3 mL in a cuvette and record the absorbance at 540 nm. 1511 
Blank: For blank tests, follow the same procedure but no enzyme is added before the 3 1512 
minutes incubation time.  1513 
Pipetting scheme for three different enzyme concentrations: 1514 
Volumes in mL 1st enzyme 2nd enzyme 3rd enzyme Blank 
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concentration concentration concentration 
Substrate (potato starch) 1.00 1.00 1.00 1.00 
Enzyme solution 0.50 0.70 1.00 - 
DNS 1.00 1.00 1.00 1.00 
2nd addition of enzyme 0.50 0.30 - 1.00 
H2O 9.00 9.00 9.00 9.00 
 1515 
Standard Curve with maltose:  1516 
Dilute the maltose solution (0.2% w/v) according to the scheme in H2O 1517 
Volumes in (mL) D1 D2 D3 D4 D5 D6 D7 Std. Blank 
Maltose solution 0.05 0.20 0.40 0.60 0.80 1.00 2.00 - 
H2O 1.95 1.80 1.60 1.40 1.20 1.00 - 2.00 
 1518 
1mL DNS reagent solution is added to each maltose standard, thereafter the tubes are boiled 1519 
for 15 minutes, cooled on ice to room temperature and 9mL of H2O are added. 1520 
Calculations  1521 
Standard Curve: 1522 
                                           
Plot the  A540nm of the Standards versus the quantity of maltose [mg] and establish a linear 1523 
regression:  1524 
                             
Enzyme activity: 1525 
                                       
     
         
 
                               
 (     )
 
 1526 
a: slope of the linear regression for standards  A540nm vs the quantity of maltose (mg). 1527 
b: intercept of the linear regression for standards  A540nm vs the quantity of maltose (mg). 1528 
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X: quantity of amylase powder (mg) added before stopping the reaction. 1529 
 1530 
Pepsin Activity Assay (EC 3.4.23.1) 1531 
References: adapted from Anson et al. 4,5 1532 
Method: Spectrophotometric Stop Reaction 1533 
Principle:  1534 
Haemoglobin + H2O 
pepsin 
> TCA soluble tyrosine containing peptides 1535 
Unit definition: One unit will produce a  A280 of 0.001 per minute at pH 2.0 and 37°C, 1536 
measured as TCA-soluble products. These units are often referred to “Sigma” or “Anson” 1537 
pepsin units. 1538 
Conditions: T = 37°C, pH = 2.0, A280nm, light path = 1 cm 1539 
Procedure: 1540 
Preparation of reagents 1541 
Substrate: Prepare a haemoglobin solution by dispersing 0.5 g haemoglobin (bovine blood 1542 
haemoglobin, ref H2500 Sigma-Aldrich) in 20 mL purified water, adjust to pH 2 with 300 mM 1543 
HCl and complete the volume to 25 ml to obtain a solution at 2% w/v haemoglobin at pH 2.  1544 
Enzyme: Prepare a stock solution of 1 mg/mL pepsin (porcine pepsin, ref. P6887 Sigma-1545 
Aldrich) in 10 mM Tris buffer, 150 mM NaCl at pH 6.5. The stock solution has to be stored on 1546 
ice or refrigerated at 4°C. Just before the assay, a range of 5 to 10 concentrations of pepsin 1547 
in 10 mM HCl has to be prepared. For instance, dilute the pepsin stock solution to prepare 1548 
the following enzyme assay solutions: 5, 10, 15, 20, 25, 30 µg/mL. 1549 
Assay: 1550 
Set the spectrophotometer at 280 nm and 20°C. Set a bench top shaking incubator fitted with 1551 
a sample holder at 37°C. 1552 
Test: Pipette 500 µL of haemoglobin solution into 2 mL Eppendorf tubes and incubate in a 1553 
shaking incubator at 37°C for 3-4 minutes to reach the assay temperature. 1554 
Add 100 µL of pepsin assay solutions for each concentration and incubate them for 10 1555 
minutes exactly. To stop the reaction, 1 mL of 5% w/v TCA (Trichloroacetic Acid) is added in 1556 
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each tube. In order to get a clear soluble phase available for absorbance measurement, 1557 
centrifuge the Eppendorf tubes at 6,000 × g for 30 minutes to precipitate remaining 1558 
haemoglobin; remove the pellet. 1559 
Place the soluble phase into quartz cuvettes and read the absorbance at 280 nm (A280 Test). 1560 
Blank: For blank tests, the same procedure is followed but the pepsin is added after the 1561 
addition of TCA, which stops the reaction. The blank absorbance is noted A280 Blank. 1562 
Because, the absorbance is a function of the pepsin concentration, a linear curve has to be 1563 
obtained. If no linear part is found, it can be due to a large amount of enzyme, and therefore 1564 
it is necessary to use more dilute enzyme assay solutions. 1565 
Calculations: 1566 
         
    28        28              
 (            )
 
Δt: duration of the reaction, i.e. 10 minutes 1567 
X = amount of pepsin powder (µg) in 1mL in the assay solution (i.e., 5, 10, 15, 20, 25, 30 µg) 1568 
1,000 = dilution factor to convert µg to mg 1569 
0.001 = ΔA280 per unit of pepsin 1570 
Check that the activity obtained is the same for each tested concentration of pepsin, to make 1571 
sure that you are in the linear part of the pepsin concentration curve. 1572 
 1573 
 1574 
Gastric and pancreatic lipase activity assay (EC 3.1.1.3) 1575 
References: Gargouri et al.6; Moreau et al.7; Carrière et al. 2,8, Erlanson and Borgström 9 1576 
Method: pH titration  1577 
Principle:  1578 
Tributyrin + H2O 
    lipase    
> butyric acid + glycerol 1579 
The gastric and pancreatic lipase activity assay are conducted by pH titration and tributyrin 1580 
as substrate. The free fatty acids released by the lipases are titrated at a constant pH by 1581 
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sodium hydroxide (0.02 - 0.1 N) during at least 5 min. The concentration of NaOH is adjusted 1582 
to allow the titrator to keep the pH as constant as possible during the titration. 1583 
Unit definition: One unit releases 1 µmol of butyric acid per minute at 37°C at the pH of the 1584 
assay: 6.0 for Human Gastric Lipase, 5.5 for Rabbit Gastric Lipase and 8 for Pancreatic 1585 
Lipase. These units are often referred to International Units. Both, purified Human and Rabbit 1586 
Gastric Lipases show a specific activity of approx. 1,200 U/mg protein on tributyrin7,10 and 1587 
human Pancreatic Lipase has a specific activity of ca. 8,000 U/mg of protein on tributyrin 2 1588 
Procedure: 1589 
Preparation of reagents: 1590 
Assay solution: Prepare 200 mL of the following aqueous solutions which vary for gastric or 1591 
pancreatic lipase:  1592 
 1593 
 Gastric Lipase Pancreatic Lipase 
 
Concentration 
[mg/L]  
Corresponding 
weight [mg] for 
200 mL 
Concentration 
[mg/L]  
Corresponding 
weight [mg] for 
200 mL 
NaCl 9,000 (150 mM) 1,800  9,000 (150 mM) 1,800  
Sodium tauro-
deoxycholate 
1,000 (2 mM) 200  2,000 (4 mM) 400  
BSA 100 (1 µM) 20 - - 
CaCl2 - - 200 40 
Tris-
(hydroxymethyl)-
aminomethane 
- - 36 7.20 
pH 
adjust with HCl (0.1M) at pH 5.5 
(RGE) or pH 6 (HGL) 
adjust with HCl (0.1 M) at pH 8 
 1594 
Titration Solution: Prepare a solution of 0.1 N sodium hydroxide (NaOH) by dissolving 2 g 1595 
NaOH in 500 mL of purified water. It is recommended to perform a back titration using 0.1 N 1596 
HCl to confirm the precise molarity of the NaOH titration solution. Alternatively, commercial 1597 
NaOH stock solutions can be used. 1598 
INFOGEST 2.0 for Nature Protocols 2019 
Page 67 of 72 
Manuscript submitted in Word format to Nature Protocols November 28 2018; Figures and Box 1 were 
subsequently added to the document. Citation: Brodkorb, A., Egger, L., . . . Recio, I. (2019). 
INFOGEST static in vitro simulation of gastrointestinal food digestion. Nature Protocols, 
doi:10.1038/s41596-018-0119-1 ; Full text version available here: https://rdcu.be/brEMd  
Enzyme: Prepare a 1 mg/mL solution by dissolving 5 mg of lipase (e.g. rabbit gastric extract 1599 
powder, RGE25-100MG Lipolytech, France) in 5 mL of purified water. Store on ice. Perform 1600 
the assay with at least 2 different amounts of the enzyme solution, i.e. 50 and 100 µL, at 1 1601 
mg/mL. 1602 
Substrate: Use tributyrin of purity grade (≥99%; ref T8626 Sigma-Aldrich)  1603 
Assay: 1604 
Set a thermo-regulated pH-stat device to 37°Cfitted with a jacketed and capped reaction 1605 
vessel (20-70 mL) and mechanical stirrer, preferentially with a 3-pale propeller. 1606 
Pour 14.5 mL of the assay solution and 0.5 mL of tributyrin into the titration vessel. Make 1607 
sure the volume of the assay is enough to ensure adequate pH-measurement, i.e., the pH 1608 
electrode is correctly immersed. By switching on the mechanical stirring of the apparatus, 1609 
tributyrin will get dispersed to form a fine oil-in-water emulsion after 3-5 min at 37°C.  1610 
 1611 
Switch on the automated delivery of titrant solution (0.1 N NaOH) to monitor the pH and 1612 
adjust it at the selected pH end-point of titration, i.e., pH 5.5 for rabbit gastric lipase, pH 6.0 1613 
for human gastric lipase or pH 8.0 for pancreatic lipase. Add 50 or 100 µL of the enzyme 1614 
solution. Monitor the rate of titrant solution (NaOH) which is required to maintain the pH 1615 
constant at 37°C due to the release of free fatty acids. These conditions allow measuring 1616 
linear kinetics of free fatty release for at least 5 minutes. 1617 
If pancreatic lipase does not contain colipase, add colipase at a molar excess (ratio of 2:1 1618 
colipase:lipase) before adding the enzyme. 1619 
Calculations: 1620 
     
         
 
  (    )      
     
   
 1621 
R(NaOH): Rate of NaOH delivery in μmol NaOH per minute, i.e., μmol free fatty acid titrated 1622 
per minute  1623 
v: volume [μL] of enzyme solution added in the pH-stat vessel 1624 
[E]: concentration of the enzyme solution [mg powder/mL] 1625 
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F: correction factor to take into account the partial ionization (and titration) of fatty acids at 1626 
the pH of the assay. Only for the titration of butyric acid at pH 5.5, a correction factor F of 1627 
1.12 has to be applied.  1628 
Check that the activity obtained is the same for each tested concentration of lipase, to make 1629 
sure that you are in the linear part of the enzyme concentration curve. 1630 
 1631 
Trypsin Activity Assay (EC 3.4.21.4)  1632 
References: adapted from Hummel11 and following recommendations from the Worthington 1633 
laboratory 1634 
Method: Kinetic spectrophotometric rate determination 1635 
Principle:  1636 
TAME + H2O 
trypsin 
> p-Toluene-Sulfonyl-L - Arginine + Methanol 1637 
Unit definition: One unit hydrolyses 1 µmol of p-toluene-sulfonyl-L-arginine methyl ester 1638 
(TAME) per minute at 25°C and pH 8.1 1639 
Unit conversion: 1 TAME Unit = 19.2 USP/NF Units = 57.5 BAEE Units 1640 
Conditions: T = 25°C, pH = 8.1, A247nm, Light path = 1 cm 1641 
Preparation of reagents 1642 
Substrate: TAME (ref. T4626 Sigma-Aldrich) at 10 mM is prepared and dissolved in purified 1643 
water. 1644 
Enzyme: Prepare at least 2 concentrations of trypsin (porcine trypsin, ref. T0303 Sigma-1645 
Aldrich) ranging between 10-20 µg/mL in 1 mM HCl.  1646 
Assay solution: 46 mM Tris/HCl buffer, containing 11.5 mM CaCl2 at pH at 8.1 and 25°C.  1647 
Assay: 1648 
Set the spectrophotometer at 247 nm and 25°C. 1649 
Test: Pipette 2.6 mL of assay solution and 0.3 mL of the substrate (10 mM TAME) into 1650 
quartz cuvettes, mix by inversion and incubate in spectrophotometer at 25°C for 3-4 minutes 1651 
to achieve the temperature. 1652 
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Add 100 µl of each concentration of trypsin solutions and record in continuum the 1653 
absorbance increase at 247 nm (ΔA247) during 10 min, until levelling off. Determine the slope 1654 
ΔA247 from the initial linear portion of the curve. If no linear part is found, repeat the test with 1655 
a lower or higher amount of enzyme. 1656 
Blank: For blank assays, follow the same protocol by replacing the enzyme with buffer 1657 
(equilibration is usually reached faster, 5 min). The blank slope, ΔA247, should be close to 1658 
zero. 1659 
Calculations: 1660 
The slopes ΔA247 [unit absorbance/minute] are established for both the blank and the test 1661 
reactions by using the maximum linear rate over at least 5 minutes:  1662 
         
     2          2                
 (       )
 
ΔA247: slope of the initial linear portion of the curve, [unit absorbance/minute] for the Test 1663 
(with enzyme) and ΔA247 Blank without enzyme 1664 
540: molar extinction coefficient (L/(mol × cm) of TAME at 247 nm. 1665 
3: Volume (in millilitres) of reaction mix 1666 
X: quantity of trypsin in the final reaction mixture (quartz cuvette) [mg] 1667 
Check that the activity obtained is the same for each tested concentration of trypsin, to make 1668 
sure that you are in the linear part of the enzyme concentration curve. 1669 
 1670 
Chymotrypsin activity assay (EC 3.4.21.1)  1671 
References: adapted from Hummel11 and Rick12  1672 
Method: Kinetic spectrophotometric rate determination 1673 
Principle:  1674 
BTEE + H2O 
chymotrypsin 
>   N - Benzoyl - L - Tyrosine + Ethanol 1675 
Unit Definition: One unit of chymotrypsin hydrolyses 1.0 µmol of N-Benzoyl-L-Tyrosine 1676 
Ethyl Ester (BTEE) per minute at pH 7.8 and 25ºC. 1677 
Conditions: T = 25°C, pH = 7.8, A256nm, Light path = 1 cm 1678 
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Preparation of reagents: 1679 
Substrate: Dissolve the substrate, BTEE (ref. B6125 Sigma-Aldrich), at a concentration of 1680 
1.18 mM in methanol/purified water. Weigh 18.5 mg of BTEE, dissolve it in 31.7 mL of 1681 
absolute methanol and complete to 50 mL with deionized water in a 50 mL volumetric flask.  1682 
Enzyme: The enzyme is dissolved in 1 mM HCl. Prepare at least 2 concentrations of 1683 
chymotrypsin (porcine chymotrypsin, ref. C7762 Sigma-Aldrich) ranging between 10-30 1684 
µg/mL in 1 mM HCl.  1685 
Assay solution: 80 mM Tris/HCl buffer, containing 100 mM CaCl2 at pH at 7.8 and 25°C.  1686 
Assay: 1687 
Set the spectrophotometer at 256 nm and 25°C. 1688 
Test: Mix 1.5 mL of the assay solution and 0.3 mL of the substrate (1.18 mM BTEE) into 1689 
quartz cuvette, mix by inversion and incubate in spectrophotometer at 25°C for 3-4 minutes 1690 
to achieve temperature equilibration. Add 100 µl of each concentration of the chymotrypsin 1691 
solutions and record the absorbance increase ΔA at 256 nm (ΔA256) during 10 min in 1692 
continuum, until levelling off. Determine the slope ΔA256 from the initial linear portion of the 1693 
curve. If no linear part is found repeat the test with a lower or higher amount of enzyme. 1694 
Blank: For blank assays, follow the same protocol by replacing the enzyme with buffer only 1695 
(equilibration is usually reached faster, 5 min). The blank slope ΔA256 Blank should be close 1696 
to zero. 1697 
Calculations: 1698 
The slopes ΔA256 [unit absorbance/minute] are established for both the blank and the test 1699 
reactions by using the maximum linear rate over at least 5 minutes:  1700 
         
     2 6       2 6              
 ( 6     )
 
ΔA256: slope of the initial linear portion of the curve, [unit absorbance/minute] for the Test 1701 
(with enzyme) and ΔA256 Blank without enzyme 1702 
964: molar extinction coefficient L/(mol × cm) of BTEE at 256 nm. 1703 
3: Volume (in millilitres) of reaction mix 1704 
X: quantity (mg) of chymotrypsin in the final reaction mixture (quartz cuvette)  1705 
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Check that the activity obtained is the same for each tested concentration of chymotrypsin, to 1706 
make sure that you are in the linear part of the enzyme concentration curve. 1707 
 1708 
Pancreatin 1709 
The amount of pancreatin is normalized to the trypsin activity. However, to digest fat 1710 
containing food, the lipase activity should be recorded as well. Therefore, to measure the 1711 
enzyme activities of the pancreatin (porcine pancreatin 8 x USP specifications, ref P7545 1712 
Sigma-Aldrich), the protocols are the same as described above. For trypsin (or chymotrypsin) 1713 
Pancreatin is dissolved in 1 mM HCl (pH 3). Pancreatin is difficult to dissolve, mix during 10 1714 
minutes using a magnetic stirrer and then keep the solution on ice or at refrigerated 1715 
temperature 4°C to prevent loss of activity. Dilute the pancreatin to a concentration ranging 1716 
between 0.1 to 1 mg/mL and measure at least 3 different dilutions. Vortex pancreatin before 1717 
pipetting it to the enzyme reaction vessel. To measure the lipase activity in pancreatin, 1718 
dissolve it in 150 mM NaCl at pH 6.8 (pancreatic lipase is degraded at low pH), and follow 1719 
the above procedure to record lipase activity. 1720 
 1721 
Bile salts in bile 1722 
The concentration of bile salts in the bile (fresh or commercial) can be measured with a 1723 
commercial kit (bile acid kit, 1 2212 99 90 313, DiaSys Diagnostic System GmbH, Germany, 1724 
MAK309-1KT, Merck or similar) according the supplier’s protocol. Measure the bile at 1725 
different concentrations bearing in mind the linearity range of the kit. 1726 
 1727 
  1728 
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